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Synopsis 
This thesis explores two major health themes in community-dwelling older men. The first 
theme is the natural history of common urological conditions (overactive bladder (OAB) and 
elevated post-void residual urine volume (PVR)). The second theme is the association 
between lower urinary tract symptoms (LUTS) and falls. 
The first two research findings chapters (Chapters 3 and 4) describe the natural history of 
OAB and elevated PVR. Although previous studies suggest that OAB and elevated PVR often 
resolve naturally, understanding of their natural history is insufficient. If natural remission of 
these conditions can be expected, more men may be treated conservatively and avoid 
potential adverse effects of the treatments. 
In a representative sample of community-dwelling men aged 70 and older in the Concord 
Health and Ageing in Men Project (CHAMP study) (n=1705), LUTS were assessed using the 
International Prostate Symptoms Score (IPSS) and the International Consultation of 
Incontinence Questionnaire (ICIQ) and urodynamic tests were conducted at baseline and 
two-year and five-year follow-up. 
Chapter 3 describes the natural history of OAB in the absence of neurological disorders. 
Men with prostate cancer and those with history of urological treatment at baseline were 
also excluded. Of the 98 men with OAB at baseline, 28 (29%) received treatment for either 
benign prostatic enlargement (BPE) or OAB over five years. Of the 70 men who remained 
urologically intact during follow-up, 23 (33%) had natural and sustained remission at two-
year and five-year follow-up. 
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Chapter 4 describes the natural history of elevated PVR in the absence of neurological 
disorders. Men with prostate cancer and those with history of urological treatment at 
baseline were also excluded and PVR was considered valid when the voided volume was 
150mL and over. Of the 325 men with a baseline PVR of less than 400mL, 15 (5%) received 
surgery for BPE or indwelling catheterization over five years. In all 101 men with a baseline 
PVR of less than 400mL who remained urologically intact during follow-up and had valid 
follow-up PVR data, PVR did not exceed 400mL at either two-year or five-year follow-up. 
Chapters 3 and 4 indicate that, in the absence of neurological disorders, OAB and elevated 
PVR often resolve naturally in older men living in the community. This may support initial 
conservative management in men with these conditions. 
The next three chapters (Chapters 5 to 7) investigate the association between LUTS and falls 
in community-dwelling older men. A previous systematic review has identified falls as a 
potential adverse outcome of LUTS but showed that there is limited evidence for this 
association in men. Since the prevalence of both LUTS and falls are high, the associations 
between them may have significant implications for falls prevention. 
Chapter 5 is a systematic review of the associations between LUTS and falls, injuries and 
fractures in community-dwelling older men. This review found that incontinence and 
storage symptoms have been associated with falls, and that the contribution by each of 
incontinence and storage symptoms that often coexist in men were unclear.  
Chapter 6 then examines the contribution of each LUTS to falls risk using the CHAMP study 
data.  One thousand three hundred and ninety men without neurological disorders, poor 
mobility and dementia were included in the analyses. Intermediate to high IPSS storage 
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subscores (IPSS-S) and high voiding subscores (IPSS-V) were associated with falls (adjusted 
IRR=1.73, 95%CI: 1.24-2.40 for intermediate IPSS-S, adjusted IRR=1.81, 95%CI: 1.13-2.90 for 
high IPSS-S, adjusted IRR=1.41, 95%CI: 0.97-2.04 for intermediate IPSS-V, and adjusted 
IRR=1.98, 95%CI: 1.09-3.60 for high IPSS-V). Urgency incontinence was associated with falls 
(adjusted IRR=2.57, 95%CI: 1.54-4.30) and intermediate to high IPSS storage subscores 
without urgency incontinence were also associated with falls (adjusted IRR=1.72, 95% CI: 
1.24-2.38). 
Lastly, since it is unclear whether LUTS directly cause falls or are merely markers of other fall 
risk factors, the urology clinic pilot study at Concord Hospital presented in Chapter 7 
investigated the circumstances of falls in community-dwelling older patients with LUTS of 
both sexes to find out whether LUTS directly precipitate falls. Twelve patients who had had 
falls in the previous 12 months reported the circumstances of 26 falls in total. Although 23 
out of these 26 falls were not directly related to voiding, three occurred in those with OAB 
on their way to the toilet both in daytime and night. 
Chapters 5 and 6 show that urgency incontinence and storage and voiding symptoms are all 
associated with falls in community-dwelling older men. And Chapter 7 suggests that it is 
possible that urgency and nocturia directly precipitate a minority of falls in older people 
with LUTS although causality is still unclear. Circumstances of falls should be further 
investigated to generate more hypotheses about what types of intervention may be 
incorporated into falls prevention strategies and these need to be tested for efficacy. Also, 
trials to treat LUTS should consider including falls as an outcome. 
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1. Background  
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1.1 Overview of lower urinary tract symptoms (LUTS) in older men 
LUTS refers to symptoms related to the lower urinary tract (bladder, prostate and urethra) 
and can be classified into storage symptoms, voiding symptoms and post-micturition 
symptoms (1).  Storage symptoms are irritative symptoms that occur during the storage 
phase in the bladder such as urgency, daytime frequency and nocturia. Voiding symptoms 
are symptoms that indicate either obstruction or inadequate contraction of the bladder 
such as weak or intermittent stream and straining to void. Post-micturition symptoms are 
symptoms that occur immediately after micturition such as feeling of incomplete emptying 
and post-micturition dribble. These symptoms are common in older men and result in 
considerable morbidity as will be discussed in section 1.2. 
Male LUTS were once called ‘prostatism’ because all LUTS were thought to arise from 
benign prostatic enlargement (BPE) (2). A better understanding of LUTS was developed by 
the use of pressure flow urodynamic studies which revealed that male LUTS actually have a 
wider variety of causes than BPE alone, such as detrusor overactivity (DO) or detrusor 
underactivity (DU) (3). It is difficult to differentiate the causes for LUTS from symptoms 
because the symptoms are not specific to underlying pathology and different types of 
voiding dysfunction often coexist in older men. Pressure flow urodynamic study is required 
to diagnose the causes but this test is invasive. As LUTS are common, men are often treated 
empirically, targeting symptoms that are the most bothersome, and invasive investigation is 
often spared unless the symptoms do not respond to empirical treatment. In keeping with 
this, most clinical practice guidelines provide guidance on the management of LUTS based 
on symptoms rather than the treatment of particular underlying pathology such as benign 
prostatic enlargement (BPE), DO and DU (4). 
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The International Prostate Symptom Score (IPSS) is a scoring system that is most often used 
to assess LUTS in clinical practice (5). IPSS consists of storage symptoms (urgency, frequency 
and nocturia) and voiding symptoms (incomplete emptying, intermittency, weak stream and 
straining to void) and IPSS subscores for each category of symptoms can be calculated 
separately (6). The US Osteoporotic Fractures in Men (MrOS) study reported the prevalence 
of LUTS in community-dwelling men aged 65 and over using the International Prostate 
Symptom Scores (IPSS) (7). LUTS were absent (IPSS of 0) in 2.3%, mild (IPSS of 1 to 7) in 
51.6%, moderate (IPSS of 8 to 19) in 39.6% and severe (IPSS of 20 to 35) in 6.6% and the 
severity of LUTS increased with age.  
Common types of voiding dysfunction among older men are discussed below. The choice of 
common conditions in older men and the course of treatment discussed below are based on 
our previous review article on older men’s voiding symptoms (8). 
1.1.1 Overactive bladder (OAB) and urgency incontinence 
OAB is defined by the International Continence Society (ICS) as “urgency, with or without 
urgency incontinence, usually with frequency and nocturia” where “there is no proven 
infection or other obvious pathology” (1). This definition is based on symptoms that are 
suggestive of DO in urodynamic studies. The severest form of OAB is urgency incontinence 
where urgency results in leakage of urine. A US telephone survey reported that the 
prevalence of OAB without urgency incontinence was 24 % and the prevalence of OAB with 
urgency incontinence was 10% in community-dwelling men aged 75 and over (9). A Finnish 
population-based mail survey in men and women between ages 18 and 79 reported that 
one in seven people with urgency has at least moderate bother (10). 
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Causes of OAB are classified into neurogenic and idiopathic (non-neurogenic). Neurological 
disorders that may be related to OAB includes multiple sclerosis, spinal cord injury, stroke 
and neurodegenerative diseases. Damage to the brain can decrease suprapontine inhibition 
of the micturition reflex and damage to the spinal cord leads to the emergence of abnormal 
micturition reflexes both resulting in DO (11). If no neurological disorder is present, OAB is 
assumed to be idiopathic. 
Treatment should start with lifestyle modification such as reducing intake of caffeine and 
alcohol, which are mild diuretics, and avoiding fluids before going out or before bedtime (4). 
Absorbent products may also be used to achieve social continence (4). Behavioural 
modification such as bladder retaining to increase the bladder capacity, double voiding to 
empty the bladder and urethral milking to avoid post-void dribbling may also reduce the 
symptoms (12). If such conservative management fails, anticholinergic drugs may be used to 
relax the detrusor. The problem with anticholinergic medications is that they have a 
potential to cause significant adverse effects on cognitive and physical function especially in 
older people (13). 
Population-based studies in older men have reported high remission rates of OAB and 
incontinence but these studies did not account for urological treatment (14, 15). It is, 
therefore, unclear if the remission occurred naturally or in response to treatment. Our 
hypothesis is that spontaneous remission of OAB occurs without treatment in some men. If 
so, it would be useful to know how likely spontaneous remission would be so that men will 
be spared from potential adverse effects of anticholinergic medications. 
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1.1.2 Bladder outlet obstruction (BOO) / underactive bladder (UAB) 
BOO and UAB are discussed together here because the clinical presentation are similar. BOO 
refers to obstruction in any part of the lower urinary tract (bladder, prostate and urethra). 
BOO is most often caused by benign prostatic enlargement (BPE) in older men but other 
causes include urethral stricture and bladder neck obstruction. UAB is a condition where the 
bladder does not contract effectively to void urine and this can be of neurogenic and/or 
myogenic aetiology (16). Detrusor underactivity (DU) is a urodynamic finding that is 
consistent with UAB. Both conditions primarily cause voiding symptoms such as weak 
stream and straining that reflect failure to empty the bladder.  Inadequate emptying at each 
void may also result in some storage symptoms such as frequency and nocturia. In severe 
cases, post-void residual urine volume (PVR) may also increase which can result in 
complications such as renal failure and urosepsis (16). As the symptoms and elevated PVR 
are not specific to each of BOO and UAB, these two conditions can only be differentiated by 
pressure flow urodynamic studies. 
A Korean study of urological patients aged 65 and over who underwent urodynamic studies 
reported that 53% of the men had DU alone and an additional 18% had both DU and BOO 
(17). Although these patients presumably have undergone urodynamic studies because of 
persistent symptoms that did not respond to empirical treatment, DU and its coexistence 
with BOO is often encountered in clinical practice.  
Although elevated PVR is often found incidentally in older people, its prevalence in the 
general population has not been studied. In community-dwelling men aged 70 and over in 
the Concord Health and Ageing in Men Project (CHAMP study), PVR was 0 to 49mL in 57%, 
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50 to 99mL in 18%, 100 to 199mL in 21%, 200 to 399mL in 4% and 400mL and over in 2% 
(unpublished data). Elevated PVR up to 200mL is common from our data. 
In treating older men with predominantly voiding symptoms and/or elevated PVR, it is 
important to identify medications with anticholinergic effect that can reduce the 
contractility of the bladder especially in older people where polypharmacy is common. A 
Japanese study reported that medications with anticholinergic properties such as anti-
Parkinson drugs, antidepressants and antipsychotics were commonly prescribed in patients 
who were receiving medications to treat LUTS (18) and the authors urged a medication 
review before pharmacologically treating LUTS. Epidemiological studies of LUTS also need to 
take the effect of these medications into account. 
Lifestyle and behavioural modification as discussed above for OAB may also be given as 
needed to manage symptoms. If such conservative management fails, medications such as 
alpha-blockers and 5-alpha reductase inhibitors may be considered for BPE. Eligibility for 
cavitating prostate surgery, however, should be assessed with caution in older men because 
such surgery may not be very effective if severe DU coexists (3) and it has high complication 
rates in older men including stress incontinence. Ultimate treatment for DU is 
catheterization. Since intermittent catheterization is technically difficult in older people, 
indwelling catheterization is often the first choice but can result in in recurrent urinary tract 
infections (UTI) and also carries a risk of urethral trauma. 
Moreover, DO and DU may coexist in older people. This condition is called detrusor 
hyperactivity with impaired contractility (DHIC) where patients have irritative symptoms but 
the detrusor contractility is inadequate to empty the bladder at the same time. In such 
patients, anticholinergics may further increase PVR. The above Korean study also revealed 
25 
 
that as many as 38% of the men aged 65 and over who underwent urodynamic studies had 
both DU and DO (DHIC) (17). Clinicians may often encounter this unresolved challenge 
where no guidelines for treatment exist. 
With regards to the natural course, the US Olmsted County study of urinary symptoms and 
health status reported that extreme values of PVR tended to move closer to the mean over 
time (19). Although this may indicate that most cases of elevated PVR resolve without 
causing complications, it is unclear what level of elevated PVR is safe to be managed 
conservatively. Our hypothesis is that elevated PVR do not keep increasing in a majority of 
men. Knowing the natural history of different levels of elevated PVR may help guide the 
decisions as to whether men with elevated PVR need intervention or to be followed up 
closely. 
1.1.3 Stress incontinence 
Stress incontinence refers to leakage of urine caused by elevation of abdominal pressure 
and only occurs iatrogenically in men, such as after radical prostatectomy and radiotherapy 
for prostate cancer and cavitating prostate surgery for BPE. This is because the long urethra 
and the prostate protect men from leakage even when abdominal pressure is elevated. 
Details will not be discussed further because, in this thesis, the focus is on common 
conditions that occur naturally to older men. 
 
1.2 Consequences of LUTS 
Of all LUTS, OAB and incontinence, have been particularly associated with adverse outcomes 
such as impaired quality of life (QOL) (9, 20). Amongst symptoms of OAB, urgency 
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incontinence seems to affect QOL the most. Men with OAB with urgency incontinence have 
a higher prevalence of depression and are more likely to alter activities compared to men 
with OAB without urgency incontinence after adjusting for potential confounders (21). 
These associations were stronger in men than in women (21). 
The consequences of LUTS may not be limited to impaired QOL, depression and social 
isolation. A Spanish study of patients admitted to a geriatric rehabilitation unit reported that 
patients with urinary incontinence had a higher risk of first-time nursing home admission 
compared with those without, after adjusting for potential confounders (22). Incontinence 
may add to carer burden and, therefore, may influence decisions whether or not to place a 
family member in a nursing home. 
One adverse outcome of LUTS that has been looked at to a limited degree is falls. A 
systematic review identified nine studies that examined the associations between LUTS and 
falls (23). All studies were in older adults aged at least 65, the sample sizes ranged from 127 
to 6049, but most studies were exclusively (n=4) or predominantly (n=3) of women. They 
found that urgency incontience but not stress incontinence was associated with falls, and 
also identified studies that found positive associations of frequency and nocturia with falls. 
Our hypothesis is that some LUTS are also associated with falls in men. This association may 
have significant implications for falls prevention because both LUTS and falls are common in 
older people and falls can have serious impact on older people’s health and independence 
as will be discussed in section 1.4. 
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1.3 Incontinence and falls as components of the geriatric syndromes 
Of all LUTS, incontinence has been most often examined in association with falls (23) and 
both incontinence and falls (instability) are components of the original set of the geriatric 
syndromes that Isaacs proposed as the ‘Giants of the Geriatrics’ in 1975, along with 
immobility and intellectual incapacity (24). Isaacs saw the Giants to be age-related 
conditions that can lead to further functional deterioration in older people. 
In community-dwelling men aged 70 and over in the CHAMP study, we have found that 
incontinence and falls were the more common geriatric syndromes compared to poor 
mobility and dementia (25). The prevalence of recurrent falls in a year increased from 6% in 
men aged 70 to 74 to 13% in men aged 85 to 89, and the prevalence of incontinence that 
occurs more than once a week increased from 5% in men aged 70 to 74 to 15% in men aged 
85 to 89. 
Although only incontinence was a part of Isaac’s Giants of Geriatrics, other LUTS also 
become more common with age. The IPSS assesses storage and voiding symptoms but does 
not include incontinence. In community-dwelling men aged 70 to 74 in the CHAMP study, 
LUTS were absent or mild (IPSS of 0 to 7) in 67%, moderate (IPSS of 8 to 19) in 27% and 
severe (IPSS of 20 to 35) in 6% (unpublished data). Moderate to severe LUTS were more 
prevalent in men aged 85 to 89: absent or mild in 58%, moderate in 32% and severe in 10% 
(unpublished data).  
The associations between LUTS and falls may be of interest to clinicians and the community, 
considering the prevalence of each of LUTS and falls. In addition, the potential association 
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does raise the question as to whether improving LUTS or behavioural modification around 
LUTS can reduce fall risk. 
 
1.4 Consequences of falls 
Falls result in significant morbidity and threaten the independence of older people. Five 
percent of falls in people older than 65 result in hospitalization (26). In addition, falls can 
lead to institutionalisation, with one study finding that 10% of patients aged 70 and over 
hospitalized for falls become first-time residents of residential care facilities (27). This could 
be a result of physical and mental decline following the fall, but having a major fall may also 
influence the decision to place family members to nursing homes. 
Adverse effects of falls are not limited to injuries directly caused by falls. Older adults are 
known to restrict their activities due to fear of falling (28). This self-imposed restriction has a 
potential of leading to social isolation and further physical and mental deterioration. 
 
1.5 Risk factors for falls 
Falls are usually multi-factorial in older adults, who may have multiple predisposing factors 
that impair balance, gait and strength; when some precipitating factors such as acute illness 
or environmental hazard are added, the individual’s compensatory ability fails and he or she 
may fall (29). 
Fall risk factors and interventions to prevent falls are usually discussed separately for 
institutionalized adults and non-institutionalized adults (30, 31). This is because the 
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incidence of falls is three times higher in residential care facilities and factors contributing to 
falls are different between these populations. In one study, 41% of the falls in non-
institutionalized adults were attributed to environmental hazards whereas, in 
institutionalized adults, only 16% of the falls were caused by environmental hazards. In the 
latter setting, a majority of the falls were due to intrinsic factors such as weakness, gait or 
balance disorder, dizziness or vertigo (32). This thesis will focus on falls in older adults living 
in the community. 
Deandrea’s systematic review of falls risk factors identified a large number of factors that 
have been associated with falls in community-dwelling older people (33). Of these fall risk 
factors, only some may have direct causal relationships with falls, and furthermore, even 
fewer may be modifiable. Although modification of the other factors may not help prevent 
falls, they might serve as markers to efficiently identify at-risk individuals for falls who might 
benefit from multifactorial intervention. 
Likewise, it is unclear if LUTS directly cause falls or treating LUTS reduces falls. Although 
multiple LUTS often coexist in one person, no previous study has looked at the association 
of a wide range of LUTS with falls in a single study sample to determine which LUTS are 
more strongly associated with falls (23). Moreover, none of the studies that have examined 
the association between LUTS and falls described the circumstances of falls (23). It is, 
therefore, unclear whether the association between LUTS and falls shown in previous 
studies is because LUTS cause falls or because people with LUTS tend to have other fall risk 
factors that could not be fully adjusted for in the analyses. The hypothesized mechanisms of 
how LUTS directly or indirectly cause falls include the following; people with incontinence 
may slip over leaked urine on the floor; people with urgency may fall when they rush to the 
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toilet; and nocturia may cause daytime sleepiness resulting in falls.  Knowing which LUTS 
have strong associations with falls and how older people with LUTS fall would inform what 
types of intervention may decrease fall risk in older men with LUTS.  
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1.6 Background summary, aim and thesis outline 
Figure 1.1 shows the structure of this thesis. 
 
Figure 1.1 Structure of the thesis 
 
 
As mentioned above there is some data to suggest that common urological conditions in 
older men, OAB and elevated PVR, often resolve naturally. If natural remission of these 
conditions can be expected, more men may be treated conservatively and avoid potential 
adverse effects of the treatments. Evidence about the natural history of OAB and elevated 
PVR, however, is insufficient. The aim of Chapters 3 and 4 is to describe the natural history 
of OAB and elevated PVR in community-dwelling older men. 
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In Chapter 3, the natural history of non-neurogenic OAB and urgency incontinence is 
described in the community-dwelling men in the CHAMP study. The characteristics of the 
men who had continuous remission of OAB are also examined. 
In Chapter 4, the natural history of elevated PVR including the incidence of related events is 
described in the community-dwelling men in the CHAMP study. 
As mentioned previously the systematic review by Chiarelli identified falls as a potential 
adverse outcome of LUTS but showed that there is limited evidence for this association in 
men. Since the prevalence of both LUTS and falls are high, the associations between them 
may have significant implications for falls prevention. The aim of Chapters 5 and 6 is to 
explore further the association between LUTS and falls in community-dwelling older men. 
Chapter 5 is a systematic review of the association between LUTS and falls in community-
dwelling older men. 
In Chapter 6, which builds on Chapter 5, the CHAMP study data is used to examine which 
LUTS are associated with incident falls in one year in community-dwelling older men. 
It is also unclear whether LUTS directly cause falls or are merely markers of falls risk. The 
aim of Chapter 7 is to determine if LUTS precipitate falls in both men and women. 
Chapter 7 describes the circumstances of falls in community-dwelling men and women using 
the data collected in the urology clinic survey. 
The CHAMP cohort is described in detail in Chapter 2 and the specific methods to each study 
can be found in the research findings chapters. 
  
33 
 
 
2. Methods and sample characteristics 
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This chapter describes the recruitment and data collection methods for the Concord Health 
and Ageing in Men Project (CHAMP study) and provides some data on the characteristics of 
the study population. Three of the studies in this thesis were conducted with the CHAMP 
cohort. The specific analyses used for each study and the characteristics of the study sample 
for each of the studies appear within the relevant research findings chapters. Methods of 
the systematic review and the urology clinic survey, which did not involve the CHAMP 
cohort, are also described in the research findings chapters. 
 
2.1 CHAMP study 
The lead investigators of the CHAMP study are interested in a broad range of health issues 
in older men including the aetiologies and consequences of the geriatric syndromes such as 
falls, fractures, cognitive impairment, lower urinary tract symptoms (LUTS) and functional 
disabilities. To explore a number of hypotheses related to these outcomes, they obtained 
funding from the National Health and Medical Research Council (NHMRC) in Australia to 
conduct a large prospective study on a representative sample of community-dwelling older 
men. The CHAMP study was approved by the Concord Hospital Human Research Ethics 
Committee. All participants gave written informed consent. 
2.1.1 Sample selection 
The CHAMP study involves 1705 men aged 70 years and over living in the community in a 
defined geographical area of metropolitan Sydney. The only exclusion criterion was living in 
a residential aged care facility. Men aged 70 years and over living in the three Local 
Government Areas surrounding Concord Hospital (Burwood, Canada Bay and Strathfield) 
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were identified using the New South Wales Electoral Roll, on which registration is 
compulsory. Limiting participation to men who live around the hospital and using the 
electoral roll as a sampling frame were considered to be the optimal strategies to obtain 
and maintain a representative sample of older men living in the community. Men on the 
electoral roll were sent an invitation letter to take part in the study and were telephoned a 
week later if they had a listed telephone number. Men who did not respond to the first 
letter or did not have a listed telephone number were sent a second invitation letter. 
Recruitment occurred sequentially across the study area between January 2005 and June 
2007. 
Figure 2.1 shows the recruitment process of the CHAMP study. Of the 3627 men who were 
sent invitation letters, 3005 were contacted. Most of the 622 men who could not be 
contacted did not have a listed telephone number. Of the 3005 contacted men, 190 turned 
out to be ineligible because they had moved out of the study area, had moved into a 
residential aged care facility or had died. Of the 2815 eligible men, 1511 participated in the 
study. An additional 194 eligible men living in the study area volunteered to join the study 
before they received an invitation letter after hearing about the study from friends or 
reading articles about the study in local newspapers. Participation rate is, therefore, 
calculated as (1511 from invitation letter system +194 volunteers) / (3627 invitations sent 
+194 volunteers -190 ineligibles) = 47%. 
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Figure 2.1  Recruitment of the CHAMP study 
 
 
37 
 
2.1.2 Measurement 
2.1.2.1 Baseline measurement 
Baseline data were collected between January 2005 and June 2007. The self-administered 
questionnaire and the clinic questionnaire used at baseline can be found in Appendix A. 
Men completed a questionnaire at home before coming to the study clinic at Concord 
Hospital. The questionnaire took about 45 minutes to complete and included questions on 
demographic characteristics, falls in the past year, the International Consultation on 
Incontinence Questionnaire (ICIQ) (34), the International Prostate Symptom Score (IPSS) (5), 
diagnosed medical conditions, the Older American Resource Scale (OARS) for instrumental 
activities of daily living (IADL) (35), history of surgery for benign prostatic enlargement (BPE) 
and dizziness. Medical conditions were assessed using a standardized questionnaire in 
which participants reported if a doctor had ever told them that they had diabetes, thyroid 
dysfunction, osteoporosis, Paget’s disease, stroke, Parkinson’s Disease, kidney stones, 
dementia, depression, epilepsy, hypertension, myocardial infarction, angina, congestive 
heart failure, intermittent claudication, chronic respiratory disease, liver disease, chronic 
kidney disease, arthritis or gout, and cancer. 
Men were then seen in a study clinic at Concord Hospital during a study visit which lasted 
about three hours. Variables assessed by trained personnel included a modification of Katz 
index for basic activities of daily living (BADL) (36), the Mini-Mental State Examination 
(MMSE) (37), physical performance tests (timed chair stands, usual pace walk for six meters 
and narrow balance walk), and Logmar Visual Acuity Test (38). In addition, men brought 
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medications that they had been taking daily or almost daily for at least the past month to 
the clinic visit for medication inventory.  
Urological assessments were conducted by trained nurses. Uroflowmetry was performed 
using Urodyn 1000 (Medtronic Functional Diagnostics A/S, Skovlunde, Denmark) and 
immediately afterwards, post-void residual urine volume (PVR) was measured using a 
BladderScan BVI 3000 portable scanner (Verathon Inc., Bothell, WA). The uroflow graphs 
were manually examined for artifacts. Maximum urinary flow rate and PVR were considered 
valid only when the voided volume was 150mL and over. 
Shortly after the clinic visit, the Informant Questionnaire on Cognitive Decline in the Elderly 
(IQCODE) (39) was administered with a nominated informant, usually the participant’s wife, 
by telephone. The 535 men with an MMSE score of 26 or lower and/or an IQCODE score of 
3.6 or higher were invited to have a detailed cognitive examination performed by a 
geriatrician and 395 were assessed. Diagnosis of dementia was made according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) (40) criteria 
at a consensus meeting attended by two geriatricians, a neurologist and a 
neuropsychologist. 
2.1.2.2 Follow-up measurement 
Eight-year follow-up had only just been completed at the time of submission of this thesis. 
Data up to and including five-year follow-up were utilized in the studies in this thesis. 
The above self-administered questionnaire and clinical assessment were repeated at two-
year and five-year follow-up visits. In addition, men were telephoned every four months and 
were asked whether they had had any falls or hospitalizations since the previous follow-up 
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phone call. When falls were reported, number of falls was asked and study staff excluded 
‘near-falls’ by asking if the man’s body landed on the ground, floor or other lower level (41). 
For hospitalizations, reason, date and place of admission were asked. Men who could not be 
contacted by telephone after several attempts were mailed a four-monthly questionnaire. 
 
2.1.3 Sample characteristics 
2.1.3.1 Demographic characteristics 
Table 2.1 shows the baseline demographic characteristics of the CHAMP cohort. The age 
distribution in the CHAMP cohort is similar to that of men in the study area in the 2006 
Australian Census (42). In the Census in the three Local Government Areas of Burwood, 
Canada Bay and Strathfield combined, 33% of men aged 70 and over were aged 70 to 74, 
31% were aged 75 to 79, 21% were aged 80 to 84, 11% were aged 85 to 89 and 5% were 
aged 90 and over. Varied country of birth reflects the ethnic diversity of the study area. A 
majority of men were married at baseline. 
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Table 2.1 Baseline demographic characteristics of the CHAMP cohort (43) 
Characteristic n (%*) 
    
Age group  
70-74 673 (39.5) 
75-79 536 (31.4) 
80-84 315 (18.5) 
85-89 135 (7.9) 
90-97 46 (2.7) 
  
Country of birth  
Australia 849 (49.8) 
Italy 335 (19.6) 
Great Britain 78 (4.6) 
Greece 65 (3.8) 
China 46 (2.7) 
Other 332 (19.5) 
  
Marital status  
Married/de facto 1310 (76.8) 
Widowed 220 (12.9) 
Divorced/separated 90 (5.3) 
Never married 85 (5.0) 
*Denominators for calculating percentages varied due to missing data.  
 
2.1.3.2 Overall health status 
Table 2.2 shows the baseline prevalence of self-reported diagnosed health conditions. 
Cardiovascular disease (stroke, heart attack and angina) and its major risk factors (diabetes 
and hypertension) were common, half of the men had arthritis and 11% had a history of 
prostate cancer. Table 2.3 shows the baseline prevalence of the geriatric syndromes, frailty, 
multimorbidity, polypharmacy and IADL dependence. Each of the geriatric syndromes of 
poor mobility, falls, urinary incontinence and dementia and Fried’s phenotype frailty (44) 
were uncommon, but many men had two or more medical conditions (multimorbidity), 
were taking five or more medications (polypharmacy) and were dependent in at least one 
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IADL. Table 2.4 shows self-rated overall health at baseline. Seventy one percent of the men 
rated their health as either excellent or good compared with others their age. 
Although the participation rate of the CHAMP study was 47%, the prevalence of major 
medical conditions and the proportion of men who reported excellent or good health were 
similar to the 915 men aged 70 and over in the nationally representative Men in Australia 
Telephone Survey (MATeS study) (45). 
 
Table 2.2 Baseline prevalence of self-reported diagnosed health conditions in the CHAMP 
cohort (43) 
Condition n (%) 
    
Arthritis 868 (51.7) 
Hypertension 780 (46.2) 
Heart attack 311 (18.7) 
Diabetes 308 (18.3) 
Angina 293 (17.7) 
Chronic lung disease* 217 (12.9) 
Prostate cancer 181 (10.7) 
Depression 150 (8.9) 
Stroke 143 (8.5) 
Congestive heart failure 86 (5.2) 
Hypothyroidism 38 (2.3) 
Parkinson's disease 32 (1.9) 
Denominators for calculating prevalence varied due to missing data. *Chronic lung disease 
included chronic obstructive lung disease, chronic bronchitis, asthma, emphysema and 
COPD. 
 
  
42 
 
Table 2.3 Baseline prevalence of geriatric syndromes, frailty, multimorbidity, polypharmacy 
and IADL dependence in the CHAMP cohort (25) 
Conditions n (%) 
    
Geriatric syndromes  
Poor mobility* 98 (5.8) 
Recurrent falls in previous year 144 (8.5) 
Urinary incontinence at least daily 121 (7.2) 
Dementia 93 (6.0) 
  
Fried’s frailty phenotype†  
Frail (3-5 criteria) 158 (9.5) 
Pre-frail (1-2 criteria) 679 (40.7) 
Robust (0 criterion) 833 (49.9) 
  
Multimorbidity (>2 conditions) 1170 (69.3) 
  
Polypharmacy (>5 medications) 639 (37.7) 
  
IADL dependence (>1 IADL)‡ 400 (23.7) 
IADL, Instrumental activities of daily living. Denominators for calculating prevalence varied 
due to missing data. *Poor mobility was defined as needing help with walking across a small 
room and/or transferring from bed to a chair. †For Fried’s frailty phenotype, frail was 
defined as having 3 to 5 of weight loss, weak grip strength, exhaustion, slow walking speed 
and low activity level; pre-frail as having 1 or 2 of the criteria; and robust as having none. 
‡IADL dependence was defined as needing help for at least one of the following tasks; 
telephoning, transport, shopping, meal preparation, housekeeping, management of 
medications and management of money. 
 
Table 2.4 Self-rated overall health at baseline in the CHAMP cohort 
Self-rated health* n (%) 
    
Excellent 268 (15.9) 
Good 908 (54.0) 
Fair 426 (25.3) 
Poor 59 (3.5) 
Very poor 21 (1.2) 
Denominator was 1682 due to missing data. *Response to the question “Compared to other 
people your own age, how would you rate your overall health?” in the Short Form-12 (SF-
12). 
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2.1.3.3 Urological Health 
Table 2.5 shows the baseline prevalence of LUTS assessed using the IPSS. Thirty seven 
percent of the men had moderate to severe LUTS. Frequent urination, urgency and weak 
stream were most commonly reported, and 57% of the men woke up at least twice during 
the night to urinate. As shown in Table 2.3, 7% of the men had incontinence at least daily. 
As shown in Table 2.2, 11% of the men had a history of prostate cancer at baseline. Table 
2.6 shows the baseline prevalence of history of treatment for LUTS. Eighteen percent had a 
history of cavitating prostate surgery at baseline and 6% were taking medications for BPH at 
baseline (alpha blockers and/or five-alpha reductase inhibitors). Only 2% were taking 
urinary-specific antispasmodics for overactive bladder (OAB). 
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Table 2.5 Baseline prevalence of LUTS in the CHAMP cohort 
LUTS   n (%) 
IPSS Low (0-7) 1008 (62.8) 
Intermediate (8-19) 466 (29.1) 
High (20-35) 130 (8.1) 
    
Incomplete  
emptying 
Not at all 1048 (63.5) 
less than half the time 376 (22.8) 
at least half the time 227 (13.7) 
   
Frequency Not at all 537 (36.2) 
less than half the time 672 (42.5) 
at least half the time 338 (21.4) 
   
Intermittency Not at all 1028 (62.4) 
less than half the time 388 (23.5) 
at least half the time 232 (14.1) 
   
Urgency Not at all 907 (55.0) 
less than half the time 455 (27.6) 
at least half the time 287 (17.4) 
   
Weak stream Not at all 903 (55.0) 
less than half the time 428 (26.1) 
at least half the time 310 (18.9) 
   
Straining Not at all 1328 (80.6) 
less than half the time 226 (13.7) 
at least half the time 93 (5.6) 
   
Nocturia 0-1 times per night 723 (43.3) 
2-3 times per night 759 (45.5) 
4+ per night 187 (11.2) 
IPSS, International Prostate Symptoms Scores. Denominators for calculating prevalence 
varied due to missing data. 
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Table 2.6 Baseline prevalence of history of treatment for LUTS in the CHAMP cohort 
Treatment n (%) 
    
Surgery for BPE 302 (17.7) 
  
Alpha blockers 91 (5.3) 
Five-alpha reductase inhibitors 12 (0.7) 
Urinary-specific antispasmodics 30 (1.8) 
BPE, benign prostate enlargement. Denominators for calculating prevalence varied due to 
missing data. 
 
  
46 
 
2.1.4 Summary of the CHAMP cohort 
The CHAMP cohort is a representative sample of community-dwelling older men and data 
about many aspects of men’s health were collected longitudinally. Although the 
participation rate was 47%, their baseline characteristics were similar to those in the 
nationally representative MATeS study cohort (45). Moreover, 22% (369/1705) declined 
follow-up in the first five years and there were further missing data for each item measured 
because the self-administered questionnaire and the clinic visit took a few hours each and 
some men found it difficult to complete these. 
The CHAMP study included the data needed to answer questions about the natural history 
of LUTS and the association between LUTS and falls in older men living in the community. 
LUTS were assessed using validated questionnaires and the study also included objective 
urological measures of urinary flow rate and PVR from urodynamic studies. These 
measurements were repeated at two-year and five-year follow-up, which provides valuable 
information about the natural history of LUTS because LUTS are known to wax and wane 
over time. The CHAMP study also collected data about a wide range of fall risk factors 
including physical performance test, making extensive adjustment for confounders possible, 
and had prospective data about incident falls. 
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3. Natural history of non-neurogenic OAB and 
urgency incontinence in community-dwelling 
older men: the CHAMP study 
 
Publication details: 
Noguchi N, Chan L, Cumming RG, Blyth FM, Handelsman DJ, Waite LM, Le Couteur, DG, 
Naganathan V. Natural history of non-neurogenic overactive bladder and urinary 
incontinence over five years in community-dwelling older men: the Concord Health and 
Ageing in Men Project. Neurourol Urodyn 2017;36(2):443-8. 
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ABSTRACT 
Aims  To describe the natural history of non-neurogenic overactive bladder (OAB) and 
urgency incontinence in community-dwelling older men. 
Methods  A representative sample of 1705 community-dwelling men aged 70 and older in a 
defined geographic area of Sydney, Australia, had their urinary symptoms assessed using 
the International Prostate Symptom Scores (IPSS) and the International Consultation of 
Incontinence Questionnaire (ICIQ) at baseline, 2-year follow-up and 5-year follow-up.  Four 
hundred and eighty eight men without neurological diseases or prostate cancer during 
follow-up, or history of urological treatment at baseline were included in the analysis. 
Urgency incontinence was defined as leakage of urine occurring more than weekly in the 
above-defined population. OAB was defined as either urgency or urgency incontinence 
according to the 2002 International Continence Society consensus. 
Results  Of the men with OAB at baseline, 29% received treatment for OAB or benign 
prostatic enlargement over five years. Of the remaining men, 33% had sustained remission 
at both 2-year and 5-year follow-ups without treatment. Of the men with OAB at 2-year 
follow-up, remission rate at 5-year follow-up was 53% in men without OAB at baseline and 
27% in men with OAB at baseline (p=0.23). No statistically significant difference was found 
in baseline characteristics between men with sustained remission and men with persistent 
symptoms. 
Conclusions  One in three older men with non-neurogenic OAB had sustained remission of 
symptoms without medical or surgical interventions. No significant predictor of sustained 
remission was identified.  
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INTRODUCTION 
Overactive bladder (OAB) is defined as the presence of urinary urgency, usually 
accompanied by frequency and nocturia, with or without urgency urinary incontinence, in 
the absence of urinary tract infection (UTI) or other obvious pathology (1). It is a common 
clinical problem among patients presenting to general practitioners and other clinicians 
including urologists, gynaecologists, geriatricians, and neurologists.  OAB may be related to 
neurological disorders such as multiple sclerosis, spinal cord injury, stroke, or 
neurodegenerative diseases (neurogenic OAB) or its exact aetiology may be unclear 
(idiopathic or non-neurogenic OAB). 
High remission rates for OAB and incontinence have been reported in population-based 
studies of older men (14, 15, 46). These descriptive studies, however, did not have data 
about medical or surgical interventions, so it is unclear if the remissions occurred naturally 
or in response to treatment. Spontaneous remission of OAB symptoms is also suggested by 
the fact that improvement of OAB symptoms is often seen in placebo arms of randomized 
controlled trials of urinary-specific antispasmodics (47). It would, therefore, be useful to 
know how likely spontaneous remission of OAB symptoms is and which older men can 
expect remission so as not to expose them to potential adverse effects of anticholinergic 
medications (48). On the other hand, since OAB significantly impairs quality of life (21), it 
would be useful if we could identify men who have little chance of spontaneous remission in 
whom it might be better to institute treatment early. 
The aim of this study was to describe the natural history of non-neurogenic OAB and 
urgency incontinence over five years in a representative sample of community-dwelling 
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older men. In addition, the study describes the characteristics of men who experienced 
sustained remission of OAB over five years. 
 
MATERIALS AND METHODS 
Study participants 
The Concord Health and Ageing in Men Project (CHAMP) is a prospective cohort study of a 
wide range of health issues in older men. Baseline data were collected between January 
2005 and June 2007. The study was approved by the Concord Hospital Human Research 
Ethics Committee. All participants gave written informed consent. 
CHAMP involves 1705 men aged 70 years and over living in a defined region of metropolitan 
Sydney. The sampling frame was the New South Wales Electoral Roll, on which registration 
is compulsory. The only exclusion criterion was living in a residential aged care facility. The 
participation rate was 47%. The details of the sample selection process have been described 
previously (43). 
Measurements 
Men completed a questionnaire at home before coming to the study clinic. This included 
questions on demographic characteristics, history of diagnosed medical conditions including 
diabetes, stroke, Parkinson’s Disease, epilepsy, and prostate cancer, lower urinary tract 
symptoms (LUTS) (the International Prostate Symptom Score (IPSS) (5) and the International 
Consultation on Incontinence Questionnaire (ICIQ)) (34), and history of surgery for BPE. 
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For the purpose of this study, urgency was defined as three points or greater (at least half 
the time) in question four in the IPSS about urgency (‘Over the past month, how often have 
you found it difficult to postpone urination?’). Incontinence was defined as more than 
weekly leakage of urine over past four weeks. For the sake of simplicity, we assumed that all 
cases of incontinence in the final analytic cohorts were urgency incontinence after excluding 
men with a history of prostate cancer, surgery for BPE and neurological diseases from the 
analysis. OAB was defined according to the International Continence Society (ICS) consensus 
in 2002 (1): either urgency or urgency incontinence by above definitions. Since self-report is 
not always consistent or reliable, we assumed the presence of urgency if men had urgency 
incontinence. The storage subscore of the IPSS (IPSS-S) was calculated as the sum of 
questions number two, four, and seven (frequency, urgency and nocturia) (6). The voiding 
subscore of the IPSS (IPSS-V) was calculated as the sum of questions number one, three, five 
and six (incomplete emptying, intermittency, weak stream, and straining to void) (6). 
Variables assessed at the interviews by trained personnel included the Mini-Mental State 
Examination (MMSE) (37) and functional disability using Katz activities of daily living (36). 
Also, participants brought medications that they had been taking daily or almost daily for at 
least the past month to the clinic visit. Poor mobility was defined as needing help with 
walking across a small room and/or transferring from bed to a chair (49). Use of urological 
medications (alpha blockers, five-alpha reductase inhibitors, and urinary-specific 
antispasmodics) and diuretics were determined from the medication inventory.  
At the clinic visit, uroflowmetry was performed using Urodyn 1000 (Medtronic Functional 
Diagnostics A/S, Skovlunde, Denmark), and post-void residual urine volume (PVR) was 
measured using BladderScan BVI 3000 (Verathon Inc, Bothell, WA, USA). The uroflow graphs 
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were manually examined for artefacts. Peak flow rate and PVR were analysed only when the 
voided volume was 150mL and over. 
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) (39) was 
administered by telephone shortly after the clinic visit. Men with an MMSE score of 26 or 
lower or an IQCODE score of 3.6 or higher had a detailed cognitive examination by a 
geriatrician. Diagnosis of dementia was reached using the Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition (DSM-IV) (40) criteria at a consensus meeting attended 
by two geriatricians, a neurologist, and a neuropsychologist. 
The self-administered questionnaire and clinical assessments were repeated at two- and 
five-year follow-up visits.  
Analysis 
Men who had neurological diseases (Parkinson’s Disease, stroke, and epilepsy) or prostate 
cancer at baseline or any follow-up points were excluded from the analyses because these 
conditions are likely to alter the course of OAB and incontinence. Men who had a history of 
surgery for BPE or were taking urological medications at baseline were excluded for the 
same reason. Having BPE surgery or starting urological medications during the five-year 
follow-up period were treated as an outcome that may indicate worsening of either OAB, 
BPE or impaired detrusor contractility. 
Baseline characteristics of the analytic cohorts for OAB and incontinence are presented as 
either means (+standard deviations (SD)) or frequency distributions by OAB or continence 
status at baseline.  
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In the analytic cohorts, numbers of men who newly received treatment over five years were 
determined by baseline OAB and continence status. In men who did not receive surgery for 
BPE or urological medications over five years, the changes in OAB and continence status at 
baseline and two- and five-year follow-up are described. The men who had either OAB or 
urgency incontinence at baseline and did not have the conditions at both two- and five-year 
follow-up were deemed to have had sustained remission. 
The characteristics of the men who experienced sustained remission of OAB without 
interventions for OAB or BPE were compared with those of the men who had persistent 
symptoms and had no interventions using Chi-square test. In addition, the characteristics of 
the men who received interventions over five years were described using proportions. 
All analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA). 
 
RESULTS 
Of the 1705 participants at baseline, 382 (22%) deceased and 369 (22%) declined follow-up, 
leaving 954 men (56%) who were followed up for five years. Of the 954 men followed up for 
five years, 428 (45%) were excluded from the analyses because they had neurological 
diseases (n=96) or prostate cancer (n=137) at baseline or developed these conditions during 
five-year follow-up, or had a history of BPE surgery or were taking urological medications at 
baseline (n=226). After applying the above exclusion criteria, data on OAB were incomplete 
for 38 men (7%) and data on incontinence were incomplete for 27 (5%) men, leaving 488 
men in the analytic cohort for OAB, and 499 men in the analytic cohort for incontinence. 
OAB and incontinence at baseline were more frequent by at least 5% in men who 
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subsequently died, in men who declined follow-up, and in men who were excluded because 
of medical conditions and treatment than in men included in the analyses (Table 3.1). 
 
Table 3.1  Baseline prevalence of OAB and incontinence by inclusion/exclusion status to the 
analysis of OAB 
  Analytical 
cohort 
Incomplete 
data 
Excluded b Lost to 
follow-up 
Deceased 
OAB 98 3 115 91 120 
No OAB 390 21 305 264 249 
Missing 0 14 8 14 13 
Total a 488 24 420 355 369 
%OAB 20% 13% 27% 26% 33% 
Incontinent 48 2 69 60 68 
Continent 440 29 355 297 306 
Missing 0 7 4 12 8 
Total a 488 31 424 357 374 
%incontinent 10% 6% 16% 17% 18% 
OAB, overactive bladder.  
aTotal does not include men with missing data. b’Excluded’ includes men who were excluded 
from the analyses because of neurological diseases, prostate cancer, and urological 
treatment. 
 
At baseline, 98 men (20%) had OAB and 48 (10%) had incontinence.  Baseline characteristics 
of men included in the analyses for OAB and incontinence are presented in Table 3.2. Mean 
ages (+SD) were 74.5 (+4.3) years (range: 70 to 92 years) in men without OAB, and 76.3 
(+4.6) years (range: 70 to 90) in men with OAB at baseline. Men with OAB had higher mean 
IPSS-V (mean+SD: 6.0+4.7) as well as IPSS-S (mean+SD: 7.5+3.1) than those without 
(means+SD: 1.7+2.5 and 2.9+2.0 respectively). There were no apparent differences in 
objective measures (peak flow rate and PVR) between men with and without OAB. None of 
the men with incontinence at baseline had either poor mobility or dementia, suggesting few 
if any had functional incontinence. 
55 
 
Table 3.2  Baseline characteristics of men included in analyses for OAB and incontinence 
    Analytical cohort 
for OAB (n=488) 
  Analytical cohort 
for incontinence (n=499) 
Baseline 
characteristics 
Baseline 
status 
no OAB 
n=390 
OAB 
n=98 
  Continent 
n=451 
Incontinent 
n=48 
Age (years) mean+SD 74.5+4.3 76.3+4.6   74.7+4.3 77.2+4.9 
Poor mobility  8 (2%) 2 (2%)  10 (2%) 0 (0%) 
Dementia  3 (1%) 2 (2%)  6 (1%) 0 (0%) 
Diuretic use  39 (10%) 16 (16%)  50 (11%) 7 (15%) 
Diabetes  57 (15%) 22 (22%)  70 (16%) 10 (21%) 
IPSS mean+SD 4.5+3.8 13.5+6.4  5.7+5.2 11.7+6.7 
IPSS-S mean+SD 2.9+2.0 7.5+3.1  3.5+2.8 6.0+3.2 
IPSS-V mean+SD 1.7+2.5 6.0+4.7  2.2+3.2 5.8+4.4 
Peak flow (mL/s) mean+SD 15.0+6.1 14.1+6.0  14.8+6.1 13.3+5.4 
PVR (mL) mean+SD 69.4+98.4 72.6+74.0  69.3+82.8 74.5+82.8 
Daily incontinence   N.A. 19 (19%)   N.A. 19 (40%) 
OAB, overactive bladder; IPSS, International Prostate Symptom Score; IPSS-S, storage 
subscore of the IPSS; IPSS-V, voiding subscore of the IPSS; PVR, post-void residual urine 
volume. 
 
Figure 3.1 shows the changes in OAB status over five years. Of men with OAB at baseline, 28 
(29%) received interventions for OAB or BPE over five years, compared to 41 (11%) men 
without baseline OAB. The natural course of OAB could be observed for the 70 men with 
OAB at baseline who did not undergo any intervention over five years. Of these men, 23 
(33%) no longer had OAB at both 2-year and 5-year follow-up (sustained remission, shown 
in bold letters in Figure 3.1). Of the men who had OAB at 2-year follow-up (shown in italics 
in Figure 3.1), remission rates at 5-year follow-up were 53% (n=20) in men without OAB at 
baseline, and 27% (n=9) in men with OAB at baseline (p=0.23). 
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Figure 3.1  Natural history of OAB in community-dwelling older men 
OAB, overactive bladder. 
a ‘Intervention’ refers to those for OAB or benign prostate enlargement. 
b Bold letters indicate sustained remission, which is 23 men out of 70 men with OAB at 
baseline whose natural course over five years was observed (33%). 
c Italics indicate the comparison of remission rates of OAB between 2- and 5-year follow-up 
by baseline OAB status.  
 
Figure 3.2 shows the changes in continence status over five years. Of men with incontinence 
at baseline, 15 (31%) received treatment over five years compared to 54 (12%) of men 
without incontinence. Of the 33 men with incontinence at baseline who did not undergo any 
intervention for OAB or BPE over five years, 17 (52%) no longer had incontinence at both 2-
year and 5-year follow-up (sustained remission, shown in bold letters in Figure 3.2). Of the 
men who had incontinence at 2-year follow-up (shown in italics in Figure 3.2), remission 
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rates at 5-year follow-up were 57% (n=16) in men without incontinence at baseline, and 
45% (n=5) in men with incontinence at baseline (p=0.72). 
 
Figure 3.2  Natural history of urgency incontinence in community-dwelling older men 
a 
‘Intervention’ refers to those for overactive bladder or benign prostate enlargement. 
b Bold letters indicate sustained remission, which is 17 men out of 33 men with incontinence 
at baseline whose natural course over 5 years was observed (52%). 
c Italics indicate the comparison of remission rates of incontinence between 2- and 5-year 
follow-up by baseline continence status.  
 
  
58 
 
Table 3.3 compares baseline characteristics of men with sustained remission of OAB to 
those who had persistent symptoms. In addition, baseline characteristics of men who were 
excluded from the analysis of natural course of OAB (those who received intervention for 
OAB or BPE during follow-up) are shown. A higher proportion of men with persistent 
symptoms of OAB had diabetes (n=13 (28%)) and were using diuretics (n=11 (23%)) at 
baseline compared with men who had sustained remission (diabetes: n=3 (13%), p=0.17, 
diuretics: n=3 (13%), p=0.31) although the differences were not statistically significant. Only 
one of 20 (5%) men with sustained remission had high baseline IPSS-V compared to six 
(13%) in men with persistent symptoms (p=0.33). No notable difference was seen in other 
variables between men who had sustained remission and those with persistent symptoms 
without intervention. 
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Table 3.3  Baseline characteristics of men with OAB at baseline by clinical course over five 
years 
  Clinical course over five years     
 No intervention for OAB or BPE   Had  
intervention 
for OAB or BPE  
n=28 
Baseline  
characteristics 
Sustained 
remission  
n=23 
Persistent 
symptoms  
n=47 p-value a 
Age >80 4/23 (17%) 10/47 (21%) 0.70 6/28 (21%) 
Poor mobility 0/13 (0%) 2/47 (4%) 0.33 0/28 (0%) 
Dementia 0/23 (0%) 2/44 (5%) 0.30 0/28 (0%) 
Diuretics use 3/23 (13%) 11/47 (23%) 0.31 2/28 (7%) 
Diabetes 3/23 (13%) 13/47 (28%) 0.17 6/28 (21%) 
IPSS >20 2/20 (10%) 9/46 (20%) 0.34 7/26 (27%) 
IPSS-S >9 6/20 (30%) 20/46 (43%) 0.30 12/26 (46%) 
IPSS-V >12 1/20 (5%) 6/46 (13%) 0.33 6/26 (23%) 
Peak flow <15mL/s 11/16 (69%) 19/35 (54%) 0.33 13/14 (93%) 
PVR >50mL 9/16 (56%) 13/31 (42%) 0.35 8/13 (62%) 
>Daily incontinence 3/23 (13%) 9/47 (19%) 0.52 7/28 (25%) 
>Weekly incontinence 13/23 (57%) 20/47 (43%) 0.27 15/28 (54%) 
OAB, overactive bladder; BPE, benign prostatic enlargement; IPSS, International Prostate 
Symptom Score; IPSS-S, storage subscore of the IPSS; IPSS-V, voiding subscore of the IPSS; 
PVR, post-void residual urine volume. 
Among men with OAB at baseline who had no intervention for OAB and BPE over 5-year 
follow-up period, sustained remission was defined as not having OAB at both 2-year and 5-
year follow-up. Men who did not have sustained remission were categorized as having 
persistent symptoms. 
aProportions were compared between men with sustained remission and those with 
persistent symptoms by Chi-square test. 
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DISCUSSION 
To our knowledge, this is the first study to explore the natural history of non-neurogenic 
OAB and urgency incontinence in a representative sample of community-dwelling older men 
taking the potential effects of treatment into account. Of 70 men with OAB at baseline who 
had no surgical or medical intervention during five-year follow-up, a third no longer had 
OAB at both two- and five-year follow-up.  
Previous population-based longitudinal studies that have examined progression and 
remission of OAB and incontinence in men (14, 15, 46) also found that OAB and 
incontinence status changed dynamically over time but did not account for medical 
treatment and conditions that can alter the clinical course. OAB and incontinence in men 
with neurological diseases may be more persistent, while incontinence caused by urological 
procedures such as TURP, radical prostatectomy, radiotherapy can be temporary. Our study 
focused on non-neurogenic idiopathic OAB and urgency incontinence.  
All cases of incontinence in the analytic cohorts were assumed to be urgency incontinence. 
Men with common causes of other types of incontinence (such as neurological diseases, 
prostate cancer, and surgery for BPE) were excluded. Since we only included men who were 
followed up for five years, the analytic cohorts consisted of relatively healthy men with low 
baseline prevalence of poor mobility and dementia, suggesting few men had functional 
incontinence. Although overflow incontinence cannot be excluded, a study of nursing home 
residents suggests that this is a rare cause of incontinence even in an older and sedentary 
population (50). 
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Remission rates of OAB between 2- and 5-year follow-up was higher in men without OAB at 
baseline compared to men with OAB at baseline, but the difference was not significant. It is 
possible that OAB of recent onset may have a better chance of remission without treatment 
but a larger study would be warranted. Remission of incontinence between 2- and 5-year 
follow-up did not seem to depend on previous continence status.  There was also a 
suggestion that taking diuretics, having diabetes and more severe voiding symptoms 
decreases the chances of spontaneous remission, but this also needs to be explored in a 
larger study as the findings were not statistically significant in this study.  
This is a population-based study where urinary symptoms were measured using validated 
questionnaires. The primary strength of our study is that, unlike past studies, we had data 
on interventions for OAB and BPE so could separate out potential improvement of 
symptoms due to interventions. In addition, we determined the rates of sustained remission 
using data from three time points as opposed to only two time points.  OAB is often a 
chronic condition that fluctuates over time: in our study, among the 38 men who had OAB 
both at baseline and at 5-year follow-up, 14 had a temporary remission at 2-year follow-up 
but developed OAB again at 5-year follow-up. Therefore, we judged that determining a rate 
of sustained remission would be more informative. 
Our study has some limitations. Firstly, the results may only apply to non-neurogenic OAB in 
healthier older men. Men who died or declined follow-up were older and larger proportions 
of these men had poor mobility, dementia and more severe voiding symptoms. Since these 
factors seemed to predict persistent PVR in our study, although they lacked statistical 
significance, it is possible that remission rate was overestimated because of the attrition. 
Secondly, even after excluding men with neurological disorders and history of urological 
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procedures, our simplified definition of urgency incontinence may have included other types 
of incontinence such as overflow and stress incontinence and post-void dribble. Thirdly, 
although we aimed to look at non-neurogenic and idiopathic OAB, we did not have 
information on transient causes of OAB such as urinary tract infection, alcohol, caffeine, or 
fluid intake. We tried to exclude these transient causes by asking about the symptoms in the 
past month using the IPSS and the ICIQ. Lastly, the sample size was too small to analyse the 
predictors of sustained remission. 
 
CONCLUSION 
One in three older men with non-neurogenic OAB had sustained remission of symptoms for 
five years without medical or surgical interventions for either OAB or BPE. No significant 
predictor of sustained remission was identified. 
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ABSTRACT 
Objectives  To describe the natural history of post-void residual urine volume (PVR) in 
community-dwelling older men. 
Design  Prospective cohort study. 
Setting  Concord Health and Ageing in Men Project 
Participants  A representative sample of community-dwelling men aged 70 and older in a 
defined geographic area of Sydney, Australia. Three hundred twenty nine men who did not 
have neurological disorders or prostate cancer at any follow-up point or a history of 
urological treatment at baseline were included in the analyses. 
Measurements  The participants underwent uroflowmetry and PVR measurement at 
baseline and two-year and five-year follow-up. PVR was considered valid when the voided 
volume was 150mL and over. 
Results  Baseline PVR were 0-49mL in 183 men, 50-99mL in 59 men, 100-199mL in 72 men, 
200-399mL in 11 men and 400mL and over in four men. Fifteen out of 325 (5%) men with a 
baseline PVR of less than 400mL had surgery for benign prostate enlargement (BPE) or 
indwelling catheterization over five years compared to three out of four men (75%) with a 
PVR of 400mL and over. In all 101 men with a baseline PVR of less than 400mL who did not 
receive urological treatment during follow-up and had valid PVR data for both two-year and 
five-year follow-up, PVR did not exceed 400mL at either follow-up time point.  
Conclusion  The majority of older men with incidentally found elevated PVR of up to 400mL 
may be managed conservatively for at least five years..  
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INTRODUCTION 
Asymptomatic, elevated post-void residual urine volume (PVR) is often found incidentally in 
older men although the prevalence in the general population has not been studied (51). 
Elevated PVR in older men is usually caused by a combination of bladder outlet obstruction 
(BOO) and underactive bladder (UAB), both of which may be multifactorial. BOO in older 
men is most often due to benign prostatic enlargement (BPE) but other causes include 
urethral stricture and bladder neck obstruction. UAB can be of neurogenic and/or myogenic 
aetiology. Elevated PVR may result in complications such as urinary retention, urinary tract 
infection (UTI) or renal impairment (16). 
From a 12-year follow-up of a random sample of community-dwelling men, Rule et al 
showed that extreme values of PVR tended to move closer to the mean, reflecting 
regression to the mean (19). It is, therefore, speculated that most cases of elevated PVR 
may resolve without complications. It is, however, unclear at what level of PVR it is safe not 
to undertake extensive investigations or treatment such as surgery or indwelling 
catheterization. 
The aim of this study was to describe the natural history of PVR in community-dwelling men 
without neurological diseases, prostate cancer, urological medications or surgery. Firstly, 
the five-year incidence of indwelling catheterization, surgical and medical treatment for 
benign prostate enlargement (BPE) and hospitalization for urinary retention and UTI was 
determined according to baseline PVR category. Secondly, the shift of PVR between volume 
categories at baseline and two- and five-year follow-up was determined in men who did not 
receive any urological treatment during follow-up.   
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METHODS 
Study participants 
The Concord Health and Ageing in Men Project (CHAMP) is a prospective cohort study of a 
wide range of health issues in older men. The study was approved by the Concord Hospital 
Human Research Ethics Committee. All participants gave written informed consent. 
CHAMP involves 1705 men aged 70 years and over living in the community in a defined 
geographical region of metropolitan Sydney. The sampling frame was the New South Wales 
Electoral Roll, on which registration is compulsory. The participation rate was 47%. The 
details of the sample selection process have been described previously (43). Baseline data 
were collected between January 2005 and June 2007. 
Measurements 
Men completed a questionnaire at home before attending the study clinic. This included 
questions on demographic characteristics, history of diagnosed medical conditions including 
diabetes, stroke, Parkinson’s Disease, epilepsy and prostate cancer, lower urinary tract 
symptoms (LUTS) (the International Prostate Symptom Score (IPSS) (5) and the International 
Consultation on Incontinence Questionnaire (ICIQ) (34)) and history of surgery for BPE. 
At the clinic visit, uroflowmetry was performed using Urodyn 1000 (Medtronic Functional 
Diagnostics A/S, Skovlunde, Denmark), and immediately afterwards, a trained nurse 
measured PVR using BladderScan BVI 3000 (Verathon Inc, Bothell, WA, USA). The uroflow 
graphs and ultrasonographic images to measure PVR were manually examined for artifacts. 
Maximum urinary flow rate (Qmax) and PVR were analysed only when the voided volume 
was 150mL and over. Indwelling catheterization was noted at the clinic visit as a reason for 
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inability to perform uroflowmetry and PVR measurement. Participants also brought to the 
clinic all prescription and over-the-counter medications that they had been taking daily or 
almost daily for at least the past month. Use of urological medications (alpha blockers, 5α 
reductase inhibitors and urinary-specific antispasmodics) and other medications with 
anticholinergic properties was determined from the medication inventory. The registered 
product information from the Medicare Information Management System was used to 
identify medications with clinically significant anticholinergic effects (52). 
The self-administered questionnaire and clinical assessments were repeated at two- and 
five-year follow-up visits. 
In addition, participants were interviewed by telephone every four months during which 
they were asked if they had been hospitalized in the previous four months, and if so, for 
what reason.  
Analysis 
Men who had neurological diseases (Parkinson’s Disease, stroke and epilepsy) or prostate 
cancer at any time point and men who had had surgery for BPE or were taking urological 
medications at baseline were excluded from the analyses because these are likely to alter 
PVR. Baseline characteristics of the analytic cohorts are presented as either means (+/- 
standard deviations (SD)) or frequency distributions. PVR was categorized by volume into 0-
49mL, 50-99mL, 100-199mL, 200-399mL and 400mL and over. Since there is no consensus 
on cut-off values for PVR, we have set these arbitrary cut-off values. 200-299mL and 300-
399mL were combined because they had small sample size and had similar results. 
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Two analyses were conducted. Firstly, the five-year incidence of indwelling catheterization, 
medical or surgical treatment for BPE and hospitalizations for urinary retention or UTI was 
determined by baseline PVR category in men with valid baseline PVR data who were 
followed up for five years (incidence of related events analysis). Changes in PVR between 
baseline and two- and five-year follow-up were described by volume category in men who 
had valid PVR data at all three time points and did not receive surgery for BPE nor urological 
medications during follow-up (changes in PVR analysis). All analyses were performed using 
SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA). 
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RESULTS 
Figure 4.1 shows the reasons for exclusions from the analyses. Of the 1705 participants at 
baseline, 382 (22%) died and 369 (22%) declined follow-up, leaving 954 (56%) who were 
followed up for five years. Of these 954 men, 428 (45%) were excluded because they had 
neurological diseases (n=153) or prostate cancer (n=137) at baseline or developed these 
conditions during the five-year follow-up, or had a prior history of BPE surgery (n=164) or 
were taking urological medications (n=69) at baseline. Of the 526 neurologically and 
urologically intact men, 196 (37%) did not have valid PVR data at baseline: 134 (25%) either 
voided less than 150mL or were unable to void at all (the median PVR for men who voided 
less than 150mL or were unable to void was 22mL); the portable scanner was unavailable 
for 33 (6%); and 29 (6%) either refused or reason was unclear. The remaining 329 men who 
had valid PVR data at baseline were included in the incidence of related events analysis. For 
the changes in PVR analysis, we further excluded 45 men (14%) who received either BPE 
surgery or urological medications during follow-up and 182 men (55%) who did not have 
valid PVR data at either two-year or five-year follow-up, leaving 102 men (31%) to be 
analysed. 
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Figure 4.1. Study participant exclusions from each analysis 
 1705 at baseline 
                  382 (22%) died 
                  369 (22%) declined follow-up 
954 (56%) followed up for five years 
                  428 (45%) ineligible 
                       153 (16%) neurological disorders at baseline or follow-up points 
                       137 (14%) prostate cancer at baseline or follow-up points 
                       164 (17%) BPE surgery at baseline 
                       69 (7%) urological medications at baseline 
526 (55%) neurologically and urologically intact* 
                  196 (37%) did not have valid PVR data at baseline 
                       134 (25%) voided less than 150mL or unable to void at all 
                       33 (6%) portable scanner was unavailable 
                       6 (1%) declined PVR measurement 
                       23 (4%) reasons unclear 
329 (63%) had valid PVR data at baseline  
(included in the incidence of related events analysis) 
                  45 (14%) received BPE surgery or urological medications during follow-up 
284 (86%) remained urologically intact* during follow-up 
                  182 (64%) did not have valid PVR data at either follow-up points 
102 (36%) had valid PVR data at baseline and follow-up points 
                   (included in the changes in PVR analysis) 
BPE = benign prostatic enlargement. PVR = post-void residual urine volume. 
Participants could have more than one reason for ineligibility. *’Neurologically intact’ refers 
to having no neurological disorders. ‘Urologically intact’ refers to having no prostate cancer, 
no history of BPE surgery and taking no urological medications. 
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Table 4.1 shows the baseline characteristics of the analytic cohorts. In the analytic cohort 
for the incidence of related events, mean age (+SD) was 75.0 (+4.6) years (range: 70 to 92 
years) and mean PVR (+SD) was 68.9 (+92.6) mL (range: 0 to 842mL). Eight percent were 
taking medications with anticholinergic properties such as tricyclic anti-depressants, beta-
blockers and medications for gout. Men who died and those who declined follow-up were 
slightly older than the analytic cohort (mean (+SD) ages of 80.1+6.1 and 77.4+5.6 
respectively). Men who did not have valid PVR data at either baseline and/or at follow-up 
points had similar baseline characteristics to men who were included in the analyses. 
 
Table 4.1. Baseline characteristics of men included in the incidence of related events 
analysis and changes in PVR analysis 
 
    Incidence of related 
interventions  
and hospitalizations analysis 
Changes in PVR 
analysis 
Baseline characteristics   n=329 n=102 
Age (years, mean+SD)  75.0+4.6 74.3+4.1 
IPSS (mean+SD)  6.2+5.4 5.4+4.4 
Weekly incontinence (n (%)) Yes 33 (10%) 6 (6%) 
 No 294 (90%) 95 (94%) 
PVR (mL, mean+SD)  68.9+92.6 79.2+98.0 
Qmax (mL/sec, mean+SD)  14.7+6.0 15.7+6.4 
Diabetes (n (%)) Yes 50 (15%) 15 (15%) 
 No 277 (85%) 87 (85%) 
Use of medications with  
anticholinergic effect (n (%)) 
Yes 25 (8%) 5 (5%) 
No 302 (92%) 97 (95%) 
SD = standard deviation. IPSS = International Prostate Symptom Score. PVR = post-void 
residual urine volume. Qmax = maximum urinary flow rate. 
The sum of numbers in each category may not add up to the total number because of 
missing data. 
  
72 
 
Table 4.2 shows the five-year incidence of indwelling catheterization, medical or surgical 
treatment for BPE and hospitalizations for urinary retention and UTI in the 329 men with 
valid baseline PVR data. Only 15 out of 325 (5%) with a baseline PVR of less than 400mL 
received surgery for BPE during the follow-up. Of the four men with a baseline PVR of 
400mL and over, three had BPE surgery, one of whom also received indwelling 
catheterization. Only five men (2%) in this analytic cohort were hospitalized for UTI and only 
two men (0.6%) for urinary retention and there was no association with baseline PVR. 
 
Table 4.2. Five-year incidence of medical or surgical treatment for benign prostate 
enlargement, indwelling catheterization and hospitalizations for urinary retention or urinary 
tract infection (n=329) 
 
Baseline 
PVR 
  Indwelling 
catheterization 
BPE 
surgery 
BPE 
medications  
only 
Hospitalization 
for UTI 
Hospitalization 
for retention 
  n n (%) n (%) n (%) n (%) n (%) 
0-49mL 183 0 (0%) 6 (3%) 11 (6%) 1 (0.5%) 1 (0.5%) 
50-99mL 59 0 (0%) 5 (7%) 5 (7%) 3 (5%)* 0 (0%) 
100-199mL 72 0 (0%) 2 (3%) 9 (13%) 1 (1%) 0 (0%) 
200-399mL 11 0 (0%) 2 (18%) 0 (0%) 0 (0%) 0 (0%) 
400mL+ 4 1 (25%)† 3 (75%) 0 (0%) 0 (0%) 1 (25%)‡ 
PVR = post-void residual urine volume. BPE = benign prostate enlargement. UTI = urinary 
tract infection. 
*One man had two hospitalizations for UTI and had BPE surgery between these events. 
Another man received BPE surgery before the hospitalization for UTI. †One man received 
indwelling catheterization after receiving BPE surgery. ‡One man who was hospitalized for 
urinary retention later received BPE surgery.   
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Table 4.3 shows the changes in PVR over five years in the 102 men who had valid PVR data 
at all three time points and did not receive BPE surgery or urological medications during 
follow-up. Shifts towards lower PVR categories were commonly observed. None of the 101 
men with a PVR of less than 400mL at baseline had a PVR of 400mL and over at either two- 
or five-year follow-up. One man with a PVR of 842mL had a PVR of 448mL at two-year 
follow-up and 853mL at five-year follow-up with voided volumes of 459mL, 641mL and 
452mL respectively. 
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Table 4.3. Changes in PVR over five years by baseline PVR category (n=102) 
Baseline n 2-year follow-up n 5-year follow-up n 
0-49mL 44 0-49mL 23 0-49mL 16 
    50-99mL 4 
    100-199mL 3 
  50-99mL 12 0-49mL 4 
    50-99mL 5 
    100-199mL 3 
  100-199mL 8 0-49mL 2 
    50-99mL 2 
    100-199mL 3 
    200-399mL 1 
  200-399mL 1 100-199mL 1 
50-99mL 25 0-49mL 5 0-49mL 3 
    50-99mL 1 
    100-199mL 1 
  50-99mL 15 0-49mL 3 
    50-99mL 3 
    100-199mL 8 
    200-399mL 1 
  100-199mL 5 0-49mL 2 
    50-99mL 2 
    100-199mL 1 
100-199mL 29 0-49mL 4 0-49mL 2 
    50-99mL 1 
    100-199mL 1 
  50-99mL 6 0-49mL 1 
    50-99mL 2 
    100-199mL 3 
  100-199mL 14 0-49mL 1 
    50-99mL 3 
    100-199mL 7 
    200-399mL 3 
  200-399mL 5 100-199mL 4 
    200-399mL 1 
200-399mL 3 50-99mL 1 50-99mL 1 
  100-199mL 2 50-99mL 1 
    100-199mL 1 
400mL+ 1 400mL+ 1 400mL+ 1 
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DISCUSSION 
This is the first study to report the natural course of different levels of elevated PVR 
including the need for treatment and adverse events requiring hospitalization. It extends 
the work of Rule et al, which involved 529 randomly selected community-dwelling men in 
the Olmsted (Mayo) cohort (19). Using a regression model, they found a negative 
correlation between baseline PVR and the mean annual change in PVR indicating that 
elevated PVR tend to decrease, but did not report the natural course of different levels of 
elevated PVR. 
The natural course of PVR observed in our study is consistent with the negative correlation 
between baseline PVR and the following change found in the study by Rule et al. We also 
observed the phenomenon of regression to the mean (19): extreme measurements in either 
direction tended to move closer to the average at the next measurement. This phenomenon 
may be particularly notable for PVR because there are wide within-individual variations in 
PVR in men even within a short period of time (53) and, therefore, the first measurement 
may capture the highest or the lowest of the fluctuating PVRs. 
Only a small minority of men in our study with a PVR of less than 400mL received surgery for 
BPE and, in men who did not receive urological treatment, PVR did not exceed 400mL over 
five years. We also found that older men with a PVR of less than 400mL rarely require 
hospitalization for urinary retention and UTI within 5 years. 
On the other hand, most of the small number of men with a high PVR of 400mL and over 
received indwelling catheterization or surgery for BPE over five years. The only person in 
this group who did not receive catheterization or BPE surgery remained in the 400mL and 
over range over the next five years. 
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Baseline PVR did not seem to predict hospitalization for urinary retention and UTI in our 
study. This is consistent with a previous study that found that PVR did not predict 
bacteriuria in asymptomatic men who underwent transrectal ultrasonography of the 
prostate (54). Similarly, another study found that PVR in untreated men with BPE does not 
predict subsequent acute urinary retention (55).  
In this study, men with conditions that are likely to alter PVR were excluded from the 
analyses. In fact, in men with prostate cancer and those with a history of BPH surgery, 
baseline PVR were lower in general and remained low during follow-up compared to the 
men included in the analyses. In contrast, in men with neurological disorders, there was no 
tendency of PVR regressing to the mean and, in a few men, PVR kept increasing and 
exceeded 400mL during follow-up. These observations support the decision we made to 
look at the natural history of PVR in men without neurological disorders, prostate cancer 
and a history of urological treatment. 
A strength of our study is that it is a population-based study of community-dwelling older 
men whereas the findings from previous studies in urological patients may not be applicable 
to asymptomatic patients. The large sample size at baseline in our study allowed for 
reasonable numbers of men to study the natural history even after excluding underlying 
neurological and urological conditions. As the study participants were not specifically asked 
to drink water before the clinic assessment, a large number of men were excluded from the 
analysis because they were unable to void sufficient urine to record valid PVR data. The 
losses were likely to be random, however, because the baseline characteristics were similar 
between the men with missing PVR data and those included in the analyses. On the other 
hand, as the bladder was not artificially distended, our study reported on natural voiding. 
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Our study has other limitations beyond excluding men with invalid PVR data and the small 
sample size in higher volume categories. Men who died or declined follow-up were older 
and larger proportions of these men had diabetes or were taking anticholinergic 
medications which can impair detrusor contractility. It is, therefore, possible that elevated 
PVR in these men was more persistent. PVR was measured with a portable ultrasound 
scanner rather than by urinary catheterization which was too invasive for a population-
based study of mostly asymptomatic participants.  In any case, measurement of PVR using 
portable scanners has a good correlation with drainage by catheterization (r=0.93) (56). 
With regards to the recording of adverse events during follow-up, urinary retention or UTI 
that did not require hospitalization or temporary catheterization would have been missed, 
and therefore the occurrence of adverse outcomes would have been underestimated. This 
underestimation would have reduced our statistical power to detect associations between 
baseline PVR and adverse events within five years of follow-up.   
In conclusion, in men with incidentally found elevated PVRs of less than 400mL, a small 
minority required surgery for BPE or indwelling catheterization over the next five years and, 
in all the men who remained untreated, PVR did not exceed 400mL over five years. The 
present findings may suggest that a majority of these men may be managed conservatively 
for at least five years. 
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ABSTRACT 
Background  Lower urinary tract symptoms (LUTS)  have been associated with falls in 
studies either exclusively or predominantly of women. It is, therefore, less clear if LUTS are 
risk factors for falls in men. 
Methods  We conducted a systematic review of the literature on the association between 
LUTS and falls, injuries and fractures in community-dwelling older men. Medline, Embase 
and Cinahl were searched for any type of observational study that has been published in a 
peer-reviewed journal in English language. Studies were excluded if they did not report 
male-specific data or targeted specific patient populations. Results were summarized 
qualitatively. 
Results  Three prospective cohort studies and six cross-sectional studies were identified. 
Incontinence, urgency, nocturia, and frequency were consistently shown to have weak to 
moderate association with falls (the point estimates of odds ratio and relative risk ranged 
from 1.31 to 1.67) in studies with low risk of bias for confounding. Only frequency was 
shown to be associated with fractures. 
Conclusions  Urinary incontinence and lower urinary tract storage symptoms are associated 
with falls in community-dwelling older men.  The circumstances of falls in men with LUTS 
need to be investigated to generate hypotheses about what types of interventions may be 
effective in reducing falls. 
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INTRODUCTION  
Falls are common among older people and often result in injuries (57). A systematic review 
by Chiarelli et al in 2009 (23) showed that lower urinary tract symptoms (LUTS) such as 
incontinence, urgency, and nocturia were associated with falls. Most studies included in the 
review, however, were exclusively or predominantly of women. The patterns of co-
occurrence and severity of LUTS are different between men and women (58). In addition, 
there may be gender-related behavioural differences in strategies to manage LUTS which 
could also influence fall risk. There has not been a systematic review on the association 
between LUTS and falls that focuses on men and it is, therefore, less clear if LUTS are risk 
factors for falls in men. 
We conducted a systematic review of the literature to determine if LUTS were associated 
with falls, injuries and fractures in community-dwelling older men. We also examined 
whether this association was influenced by type and severity of LUTS. 
 
SEARCH STRATEGY AND SELECTION CRITERIA 
The protocol was registered in the PROSPERO database (CRD42014009354). 
Data sources and searches 
One investigator (NN) carried out a systematic literature search in Medline (1966 to August 
2015), Embase (1980 to August 2015) and Cinahl (1982 to August 2015). A search strategy 
was constructed with the assistance of a medical librarian. Terms for LUTS, such as urgency, 
frequency, nocturia, and incontinence, were used in combination with terms for falls, 
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injuries, and fractures. The full search strategy for Medline is presented in Figure 5.1. In 
each database, terms were searched as index terms where available or otherwise searched 
as key words within title and abstract. All the retrieved studies on the association between 
LUTS and falls regardless of study population were utilized to identify further eligible 
studies: reference lists were examined and publications that cited these studies were also 
identified using PubMed. 
 
Figure 5.1  Search strategy for Medline 
1 exp Lower Urinary Tract Symptoms/ 
2 exp Prostatism/ 
3 exp Urinary Bladder, Overactive/ 
4 urinary urgency.tw. 
5 urinary frequency.tw. 
6 frequent urination.tw. 
7 exp Nocturia/ 
8 exp Urinary Incontinence/ 
9 incomplete emptying.tw. 
10 impaired emptying.tw. 
11 urinary intermittency.tw. 
12 intermittent urination.tw. 
13 weak stream.tw. 
14 slow stream.tw. 
15 strain* to void.tw. 
16 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 
17 exp Accidental Falls/ 
18 exp Accidents/ 
19 exp Fractures, Bone/ 
20 exp “Wounds and Injuries”/ 
21 17 or 18 or 19 or 20 
22 16 and 21 
23 limit 22 to (english language and humans) 
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Study selection 
One investigator (NN) scanned titles and abstracts, and evaluated full texts of potentially 
relevant studies referring to the prespecified inclusion and exclusion criteria as follows. 
Studies were considered for inclusion if they (1) included community-dwelling men with a 
mean age of 60 years and older, and (2) determined the associations of LUTS with falls, 
injuries and fractures. Studies were excluded if they (1) did not report male-specific data, or 
(2) targeted specific patient populations such as dementia or post-urological procedures. 
The search was limited to English language but no restriction was set for time of publication. 
Any type of observational study published in a peer-reviewed journal was included. 
Data extraction and quality assessment 
One investigator (NN) extracted data about the study characteristics and the estimates of 
associations. Another investigator (VN) checked the extracted data for accuracy. Results 
from multivariate analyses, if available, were selected. When estimates of associations were 
unavailable, unadjusted measures of association were calculated from raw data. 
Methodological quality of included studies was assessed by one investigator (NN) using an 
adaptation of the study quality check list that Stalenhoef et al used in their systematic 
review of fall risk factors (59). Another investigator (VN) verified the quality assessment. 
Data synthesis and analysis 
Data were synthesized qualitatively structured around each LUTS. Types and severity of 
LUTS were taken into account where available. Because this is a review of observational 
studies, meta-analysis was not conducted and we focused on examining possible sources of 
heterogeneity between studies (60).  
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RESULTS 
Selection of studies 
Figure 5.2 shows the selection process for relevant studies. A search of the databases 
identified 2431 studies after removing duplicates. Two thousand four hundred and eight 
were excluded after reviewing titles and abstracts including 19 that were not community-
based and 10 that were studies of women. After 23 full texts were retrieved, 14 studies 
were excluded because they did not meet the inclusion criteria: one included only younger 
men, nine did not report male-specific data, and four did not examine the association of 
interest. No additional study was identified from reference lists of retrieved articles. Nine 
studies that met all the inclusion and exclusion criteria were included in the review for 
qualitative synthesis (61-69). 
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Figure 5.2.  Selection process of relevant studies 
 
*Excluding duplicates within databases. †Reasons for exclusion after screening titles and 
abstracts include off topic (n=2362), case report (n=1), letters to editors or opinion papers 
(n=10), not community-based (n=19), study of women (n=10), and systematic review (n=6). 
‡Reasons for exclusion after assessing full text include younger participants (n=1), male-
specific data not available (n=9), did not examine the association (n=4).  
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Appraisal of studies 
Table 5.1 summarizes the characteristics and the results of the included studies. The studies 
are listed chronologically. Studies by Parsons et al and Frost et al were large prospective 
studies exclusively of men (65, 68). Another study by Nakagawa et al was also prospective 
but had a small sample size (66). The cross-sectional studies by de Rekeneire et al, Asplund 
et al, and Foley et al also had large sample size of men (63, 64, 67). The study by Parsons et 
al looked at all the symptoms in the International Prostate Symptom Score (IPSS) (5) 
questionnaire individually (65). The other studies examined only one symptom each. 
Outcomes included one or more falls (any fall) (61-63, 65, 67, 69), two or more falls 
(recurrent falls) (65), any fracture (61, 66, 68), hip fractures (64), and osteoporotic fractures 
(68). Observation or recall periods were one year for falls and five years for fractures. 
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Table 5.1  Characteristics and results of the included studies 
Note: IPSS = International Prostate Symptom Score, OR = odds ratio, RR = relative risk, HR = 
hazard ratio. 
* 5-year incidence by number of nocturnal micturition. †1/2 < of the times relative to never. 
‡ 4-5 times at night relative to 0-1 time. § Severe (20-35 points) relative to mild (0-7).  
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Methodological quality appraisal of included studies is presented in Table 5.2. Stewart et al, 
de Rekeneire et al, and Parsons et al limited participation to healthier or ambulatory 
community-dwelling men (61, 63, 65). Loss to follow-up was not a problem in any of the 
three prospective studies: Parsons et al excluded only one percent with incomplete data 
(65); and the other two were linkage studies in universal health care systems which capture 
nearly all fractures (66, 68). The time frame and frequency of occurrence of LUTS were 
specified only in the study by Parsons that employed the IPSS (65). Using this validated 
questionnaire, occurrence of LUTS was limited to the past month, frequency of the 
symptoms was taken into account, and also definitions of each LUTS were given. To 
determine LUTS, no study conducted objective tests such as pad weight test or bladder 
diary. Five studies collected data through self-administered questionnaires (64, 65, 67-69), 
and the other four used face-to-face interviews. The definitions of falls were not clearly 
stated in four studies (63, 65, 67, 69). All three prospective studies determined falls and 
fractures adequately either by close follow-up for falls (65) or by linkage to health care 
databases for fractures (65, 67). All the cross-sectional studies relied on recall over the past 
year for falls and past five years for fractures. All three prospective studies by Parsons et al, 
Nakagawa et al and Frost et al and the cross-sectional studies by Yasumura et al, de 
Rekeneire et al and Hedman et al made more extensive adjustments for potential 
confounders than for age alone (62, 63, 65, 66, 68, 69). We, therefore, considered these six 
studies to be more robust than the rest as confounding is the most important source of bias 
in observational studies (70). 
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Table 5.2  Quality of included studies 
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Stewart 
1992 520 No No No N.A. No No Yes No No 
Yasumura 
1994 366 No Yes Yes N.A. No No Yes No Yes 
de Rekeneire 
2003 1447 No No Yes N.A. No No No No Yes 
Asplund 
2006 2411 No 
Not  
clear Yes N.A. No Yes Yes No No 
Parsons 
2009 5943 Yes No No Yes Yes Yes No Yes Yes 
Nakagawa 
2010 357 Yes Yes Yes Yes No No Yes Yes No 
Foley 
2012 2352 No Yes Yes N.A. No Yes No No No 
Frost 
2012 4696 Yes 
Not  
clear Yes Yes No Yes Yes Yes Yes 
Hedman 
2013 471 No Yes Yes N.A. No Yes No No Yes 
 
*Time frame and frequency of lower urinary tract symptoms should be considered. 
†Subjective test and self-administered questionnaire are acceptable. ‡Data linkage, falls 
diary, and more than annual follow-up are acceptable. §Adjusted for other risk factors than 
age. 
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Study findings 
(i) Nocturia 
Nocturia was consistently shown to be associated with increased risk of any fall. In Parsons 
et al’s study, men who voided four to five times per night were at increased risk of falls 
relative to men who voided zero or one time (adjusted RR=1.23, 95% CI: 1.08-1.41) (65). A 
wide range of fall risk factors were accounted for in this large prospective study. Adjusted 
OR was 1.63 (95% CI: 1.00-2.68) in Stewart et al’s study in men who voided at least twice 
per night compared with men who voided zero or one time (61). This study only adjusted for 
age and determined falls retrospectively. Yasumura et al showed a positive association, but 
the confidence interval was wide as a majority of the small sample met the nocturia criteria 
of any night-time void (62). 
Parsons et al also examined the association of nocturia with recurrent falls which was 
stronger (adjusted RR=1.42, 95% CI: 1.16-1.74) than with any fall (65). 
The risk estimates for any fracture in five years were in opposite directions in the two 
studies that looked at fractures and not significant in either: adjusted HR was 2.61 (95% 
CI:0.76-8.95) in Nakagawa et al’s prospective study (66), and adjusted OR was 0.69 (95% 
CI:0.35-1.34) in Stewart et al’s cross-sectional study (61) with nocturia defined as two or 
more voids per night in both studies. The numbers of fractures over five years were limited 
in both studies (13 in Nakagawa et al’s and 38 in Stewart et al’s), resulting in wide 
confidence intervals. 
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Asplund et al reported that the recalled history of hip fractures in past five years increased 
as number of night-time voids increases, but adjustment was not made even for age and the 
information provided did not allow us to calculate OR (64). 
(ii) Incontinence 
In all three cross-sectional studies that examined the association between incontinence and 
any fall, incontinence was consistently shown to be associated with increased risk of any fall. 
The risk estimate was the largest in Foley et al’s study which did not adjust for any potential 
confounders and defined incontinence as any leakage of urine (unadjusted OR=1.86, 95% CI: 
1.51-2.29) (67). The other two studies accounted for a wide range of fall risk factors but did 
not explicitly define urinary incontinence: adjusted ORs were 1.5 (95% CI: 1.1-2.0) in de 
Rekeneire et al’s study (63) and 1.67 (95% CI: 1.13-2.47) in Hedman et al’s (69). 
None of the studies in men determined the association with falls by type or severity of 
incontinence. 
(iii) Frequency 
The large prospective study by Parsons et al found frequency, defined as having to void 
within two hours since the last void at least half of the times, to be weakly associated with 
any fall (adjusted RR=1.17, 95% CI: 1.04-1.33) relative to never having frequency (65). The 
association was slightly stronger for recurrent falls (adjusted RR=1.25, 95% CI: 1.02-1.53). 
Another large prospective study, with extensive adjustment for potential confounders, by 
Frost et al found frequency (definition not given) to be moderately associated with any 
fracture (adjusted HR=2.05, 95% CI: 1.25-3.36) (68). Although results were also given for 
osteoporotic fractures, it was not clear how they were defined.  
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(iv) Other LUTS 
The other symptoms on the IPSS (incomplete emptying, intermittency, urgency, weak 
stream, and straining) were examined for association with any fall and recurrent falls in the 
well-conducted study by Parsons et al (65). The strongest associations were found between 
urgency and any fall (adjusted RR=1.31, 95% CI: 1.17-1.47) and recurrent falls (adjusted 
RR=1.59, 95% CI: 1.33-1.89), and between straining to void and any fall (adjusted RR=1.24, 
95% CI: 1.06-1.46) and recurrent falls (adjusted RR=1.60, 95% CI: 1.27-2.02). The risks above 
were shown for men who had the symptoms at least half the time relative to those who 
never did. Other symptoms had weaker associations with falls. 
This study by Parsons et al also showed that high total IPSS (20-35 points) were associated 
with any fall (adjusted RR=1.33, 95% CI: 1.15-1.53) and recurrent falls (adjusted RR=1.63, 
95% CI: 1.31-2.02) relative to men with low IPSS (0-7 points). 
 
DISCUSSION 
In our study, we systematically reviewed the association of LUTS with falls, injuries and 
fractures in community-dwelling older men. Although studies varied in methodology, 
incontinence and storage symptoms such as urgency, nocturia, and frequency were 
consistently shown to be associated with falls. The associations were weak to moderate 
when restricted to six studies with low risk of bias due to confounding. These findings are in 
line with the past studies predominantly or exclusively of women (23). Fewer studies 
examined fracture as an outcome of which only one study showed an association between 
frequency and all fractures. No study looked at injuries as an outcome 
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As might be expected, the extent to which potential confounders were adjusted for had a 
substantial influence on observed effect sizes in included studies. The strongest evidence for 
an association between LUTS and falls comes from the study by Parsons et al (65): it had a 
large sample size, closely followed up participants for falls, assessed a wide range of LUTS 
using a validated questionnaire, and adjusted the risk estimates for an exhaustive list of fall 
risk factors that have previously been identified. 
The time frame and frequency for the occurrence of LUTS was specified only in the study by 
Parsons et al using the IPSS (65). It is preferable to ask about the occurrence of LUTS during 
a specific period of time because LUTS status is known to change dynamically over time: a 
30% annual remission rate and a 10% annual incidence of incontinence was reported in 
community-dwelling older men (15). As the majority of male incontinence includes a 
component of urgency (71), it is expected that there will be a change in storage symptoms 
such as urgency, frequency, and nocturia in keeping with the progression and remission of 
incontinence. Frequency of each symptom should also be asked because participants might 
regard symptoms that occur infrequently as insignificant. Although incontinence is not 
included in the IPSS, other validated questionnaires such as the International Consultation 
on Incontinence Questionnaire (ICIQ) may be utilized which incorporates the time frame 
and frequency of occurrence (34). The direction of bias that these ambiguities about time 
frame and frequency of symptoms may have introduced is uncertain. Administration of pad 
weight test or bladder diary may have provided better objective evidence of LUTS but may 
have been considered to be too resource intensive in large-scale studies. Thus we judged 
that the use of self-administered questionnaires which ensures privacy to be acceptable 
(72). 
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A fall is defined by World Health Organization to be ‘an event which results in a person 
coming to rest inadvertently on the ground or floor or other lower level’ (41). Most of the 
studies included in this review did not explicitly define falls. If falls were not well-defined, 
this may have inflated the number of falls because older people may regard merely losing 
balance without landing on lower level as falling (73). The impact of inclusion of ‘near-falls’ 
on the association with LUTS is uncertain. Only Parsons et al prospectively determined the 
occurrence of falls. Although the other studies that relied on recall of the past year may not 
be ideal, Mackenzie et al demonstrated that recalls of falls are fairly reliable in people aged 
70 and older (74). As has been found in most studies on fall risk factors, stronger 
associations were consistently found with ‘recurrent falls’ than ‘any fall’ in the study by 
Parsons et al (65). Single falls may occur by chance to people with no tendency to fall 
whereas recurrent fallers may be more distinct as an at-risk group for falls. 
Few studies examined fractures as an outcome. As discussed above, LUTS status changes 
dynamically over time. It, therefore, may not be appropriate to examine the association 
between LUTS at baseline and an outcome such as fractures in the following five years. 
Alternatively, it would require unfeasibly large sample size to observe sufficient number of 
fractures in a shorter period of time.  
Our review showed that both urgency and incontinence were associated with falls in men. 
As the majority of incontinence in men is known to include an urgency component (71), the 
question arises as to whether actual leakage of urine makes any additional contribution to 
fall risk beyond the sense of urgency alone. To answer this question, data needs to be 
collected to differentiate between subjects with urgency without incontinence and those 
with urgency that results in incontinence. 
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High IPSS were associated with falls. Multiple symptoms within voiding or storage symptom 
subcategories tend to coexist in older men because the voiding symptoms may reflect 
different aspects of either bladder outlet obstruction (BOO) or impaired detrusor 
contractility, and storage symptoms reflect different aspects of overactive bladder (OAB). In 
addition, voiding and storage symptoms often coexist because some of OAB may be 
secondary to BOO, and OAB and impaired detrusor contractility may coexist in older people 
as detrusor hyperactivity with impaired contractility. Hence, the IPSS may have potential in 
assessing the overall fall risk related to LUTS. Although incontinence is not included in the 
IPSS, it is not yet certain whether it carries any additional risk of falls over the symptoms in 
the IPSS as discussed above. 
There are a few limitations to our review. Firstly, the results of this review may not directly 
apply to frailer and less mobile men in the community who may be at greater risk for falls. 
Some studies limited participation to healthier men in clearly defined inclusion criteria while 
the other studies that did not limit participation in any way are still likely to have 
undersampled these men. Secondly, it is uncertain whether medical, surgical or behavioural 
interventions to LUTS alone may reduce falls in community-dwelling older people. A 
systematic review that investigated whether treating LUTS decreases falls identified two 
randomised controlled trials in nursing home residents: one that implemented a 
multidimensional intervention program including prompted toileting and physical exercise 
reported significant reduction in falls; and the other one that prescribed an anticholinergic 
agent failed to reduce falls (75). No study that reported the association between LUTS and 
falls in either men or women determined the events that precipitated the falls either. LUTS 
may directly precipitate falls or they may be merely a marker of other factors that cause 
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falls: for example, hypogonadism has been shown to often coexist with LUTS and some of 
the characteristic symptoms of hypogonadism such as depressed mood, cognitive 
impairment and decreased muscle mass and strength are risk factors of falls (76). The 
circumstances of falls should be explored to generate hypothesis about what types of 
interventions should be incorporated in multidimensional fall prevention strategies. Also, 
future trials to treat LUTS should consider including falls as an endpoint. 
 
CONCLUSION 
Urinary incontinence and lower urinary tract storage symptoms were consistently shown to 
have weak to moderate association with falls in community-dwelling older men in studies 
with low risk of bias for confounding.  
Evidence is lacking on whether medical, surgical or behavioural interventions to LUTS 
decrease fall risk in community-dwelling men. The circumstances of falls in men with LUTS 
should be explored to improve fall prevention strategies. 
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ABSTRACT 
Purpose  To determine which lower urinary tract symptoms (LUTS) are associated with 
incident falls in community-dwelling older men. 
Materials and Methods  The Concord Health and Ageing in Men Project involves a 
representative sample of community-dwelling men aged 70 and older in a defined 
geographic region in Sydney, Australia. One thousand and ninety men without neurological 
diseases, poor mobility and dementia at baseline were included in the analyses in this 
paper. LUTS were assessed using the International Prostate Symptom Score (IPSS) and 
incontinence was assessed using the International Consultation on Incontinence 
Questionnaire (ICIQ) at baseline. The IPSS subscores were calculated for storage and voiding 
symptoms. Incident falls over one year were determined by four-monthly telephone follow-
up. 
Results  Both IPSS storage and voiding subscores were associated with falls. Urgency 
incontinence was associated with falls (adjusted IRR=2.57, 95% CI: 1.54-4.30). In addition, 
intermediate to high IPSS storage subscores without urgency incontinence were associated 
with falls (adjusted IRR=1.72, 95% CI: 1.24-2.38). Other types of incontinence and urgency 
alone without urgency incontinence were not associated with falls.  
Conclusions  Both lower urinary tract storage and voiding symptoms were associated with 
falls in community-dwelling older men. Of symptoms of overactive bladder, urgency 
incontinence carries a high risk of falls. Storage symptoms also make a contribution to fall 
risk independently of urgency incontinence. Circumstances of falls among men with LUTS 
should be explored to understand how LUTS increase fall risk and to generate hypotheses 
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regarding potential interventions. Furthermore, trials to treat LUTS in older men should 
include falls as an endpoint. 
 
INTRODUCTION 
Falls are common among older people and often result in injuries (57). Lower urinary tract 
symptoms (LUTS) such as incontinence, urgency, frequency and nocturia have been 
associated with falls, but the evidence on the association is less extensive in men than in 
women (23, 77). The patterns of co-occurrence and severity of LUTS are different between 
men and women (58). In addition, there may be gender-related behavioural differences in 
strategies to manage LUTS which could also influence fall risk.  
Moreover, because multiple LUTS often coexist in one person, it is unclear which LUTS may 
potentially be targeted in strategies to reduce falls. Looking at all the important LUTS in one 
population would help identify which LUTS have stronger associations with falls. In 
particular, causally related symptoms such as urgency and urgency incontinence need to be 
examined for association with falls stratified by both of these symptoms to find out if 
urgency incontinence makes any additional contribution to fall risk over urgency alone. 
The aim of our study was to determine which LUTS are associated with incident falls over 
one year in community-dwelling older men. To explore this, each LUTS by its frequency of 
occurrence, the International Prostate Symptom Score (IPSS) (5), incontinence by type and 
urgency by the presence or absence of urgency incontinence were examined for 
associations with incident falls. 
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MATERIALS AND METHODS 
Study participants 
The Concord Health and Ageing in Men Project (CHAMP) is a prospective cohort study of a 
wide range of health issues in older men. Baseline data were collected between January 
2005 and June 2007. The study was approved by the Concord Hospital Human Research 
Ethics Committee. All participants gave written informed consent. 
CHAMP involves 1705 men aged 70 years and over living in a defined region of metropolitan 
Sydney. The sampling frame was the New South Wales Electoral Roll, on which registration 
is compulsory. The only exclusion criterion was living in a residential aged care facility. The 
participation rate was 47%. The details of the sample selection process have been described 
previously (43). 
LUTS 
Information about LUTS was collected from a self-administered questionnaire using the IPSS 
(5) and the International Consultation of Incontinence Questionnaire (ICIQ) (34).  
Nocturia was categorized into zero to one time, two to three times, and four times or more 
per night. Other symptoms in the IPSS were categorized into ‘not at all’, less than half the 
time, and at least half the time. 
The total score of the IPSS was categorized into low (0 to 7 points), intermediate (8 to 19 
points), and high (20 to 35 points) (5). The storage subscore of the IPSS (IPSS-S) was 
calculated as the sum of questions number two, four and seven (frequency, urgency, and 
nocturia) (6) and was categorized into low (0 to 3 points), intermediate (4 to 8 points) and 
100 
 
high (9 to 15 points). The voiding subscore of the IPSS (IPSS-V) was calculated as the sum of 
questions number one, three, five and six (incomplete emptying, intermittency, weak 
stream, and straining) (6), and was classified into low (0 to 4 points), intermediate (5 to 11 
points) and high (12 to 20 points). For IPSS-S and IPSS-V, the above cut-off points between 
low, intermediate, and high scores were set at the same proportions as conventional cut-off 
values of total IPSS (5). 
Incontinence was first categorized according to frequency: none or at most weekly, more 
than weekly but less than daily, and at least daily. Secondly, incontinence more frequent 
than weekly was categorized by type: incontinence without an urgency component (‘non-
urgency incontinence’, including stress and other incontinence); incontinence with an 
urgency component (‘urgency incontinence’, including urgency and mixed incontinence); 
and incontinence that occurs at most once a week was classified as no incontinence. Type of 
incontinence was determined using question number four of the ICIQ (‘When does urine 
leak?’), with the response ‘(urine) leaks before you can get to the toilet’ indicating the 
presence of an urgency component.  
To determine the individual contribution of each of urgency and urgency incontinence to fall 
risk, men were categorized into those with urgency incontinence, those with urgency 
without urgency incontinence and those with neither urgency nor urgency incontinence. For 
this analysis, urgency was defined as urgency occurring at least half the time, and urgency 
incontinence was defined as more than weekly incontinence with an urgency component. 
Lastly, post-hoc analysis was conducted to determine the contribution of storage symptoms 
as a whole to fall risk accounting for urgency incontinence. This analysis was added because 
intermediate to high IPSS storage subscores, that incorporate all overactive bladder (OAB) 
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symptoms (1) were related to falls and urgency incontinence, which is the most severe form 
of OAB, was also associated with falls. For this analysis, having storage symptoms was 
defined as intermediate to high IPSS-S (4 to 15 points). Men were classified into those with 
urgency incontinence (regardless of IPSS-S), those with storage symptoms without urgency 
incontinence, and those with neither storage symptoms nor urgency incontinence.  
Falls ascertainment 
Participants were telephoned every four months. They were asked if they had fallen in the 
previous four months, and if so, how many times they had fallen. When falls were reported, 
study staff excluded ‘near-falls’ by asking if the participant’s body had hit the ground or an 
object. The first three telephone follow-ups representing the first year of follow-up were 
utilized in this study. 
Covariates 
Information on demographic characteristics, lifetime history of diagnosed medical 
conditions (including Parkinson’s Disease, stroke, epilepsy, and arthritis), history of falls in 
previous year, and dizziness was gathered using a self-administered questionnaire. Medical 
conditions and dizziness were dichotomised into absence and presence. Country of birth 
was categorized into Australia, Italy, Great Britain, Greece, China, and other. 
Variables assessed at the clinic interviews by trained personnel included the Mini-Mental 
State Examination (MMSE) (37), functional disability using a modification of Katz activities of 
daily living (36), physical performance tests (repeated chair stands, usual pace walk and 
narrow balance walk) and visual impairment. Also, participants brought medications that 
they took daily or almost daily for at least a month prior to the clinic visit. Poor mobility was 
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defined as needing help with walking across a small room and/or transferring from bed to a 
chair (49). Time spent for each physical performance test was dichotomized into slow and 
normal/fast at the slowest quartile. Men who did not complete the tasks were categorized 
into the slowest quartile. Poor visual acuity was defined as below 20/63 on Logmar Visual 
Acuity Test (38).  Drug burden index (DBI) was calculated by adding the burden from drugs 
with anticholinergic and sedative properties (78), and was categorized into DBI=0, 
0<DBI<0.5 and 0.5<DBI (the median DBI among men who were exposed to these drugs was 
0.5). 
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) (39) is an 
informant screening questionnaire to assess cognitive decline and was administered by 
telephone shortly after the clinic visit. Men with an MMSE score of 26 or lower or an 
IQCODE score of 3.6 or higher had a detailed cognitive examination by a geriatrician. 
Diagnosis of dementia was reached using Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) (40) criteria at a consensus meeting attended by two 
geriatricians, a neurologist, and a neuropsychologist. 
Statistical analysis 
Participant characteristics were derived as means with SD or frequency distributions. 
Incidence rate ratios (IRR) for falls were estimated using negative binomial regression. 
Negative binomial regression is suitable for analysing recurrent events such as falls because 
it fully utilizes the count data in contrast to setting arbitrary cut-off values as occurs when 
logistic regression is used to analyse fall data. Negative binomial regression is a 
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generalization of Poison regression that can deal with overdispersed data and can also 
control for different follow-up lengths. 
Men with neurological diseases (stroke, Parkinson’s disease, and epilepsy), poor mobility, 
and dementia at baseline were excluded from analyses because these conditions are known 
to affect fall risk and also to cause LUTS, including functional incontinence. Each of the 
symptoms, the IPSS, urgency/urgency incontinence status and composite storage 
symptoms/urgency incontinence status were entered into separate multivariate models as 
the main explanatory variable. The following risk factors for falls that have previously been 
identified were all forced into the multivariate models regardless of their statistical 
contribution to the model to ensure face validity: age, country of birth (79), dizziness, visual 
impairment, arthritis, DBI, repeated chair stands, usual pace walk and narrow balance walk.  
All analyses were performed using SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA). 
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RESULTS 
Of the 1705 participants at baseline, 307 with neurological diseases, poor mobility, or 
dementia at baseline were excluded. After applying these exclusion criteria, an additional 
eight men (0.6%) who either withdrew from the study or died before the first telephone 
follow-up were excluded. The remaining 1390 men were included in analyses. Follow-up 
ranged from 4 to 12 months with a mean (+SD) of 11.8+1.0 months. Fall rates ranged from 
zero to 12 per year. One hundred and two men (10%) had a fall rate of one per year, and 97 
(7%) had a fall rate of greater than one per year.  
Table 6.1 shows the baseline characteristics of the included men. The mean (+SD) age was 
76.3+5.2 years. About half the men (49%) were born in Australia and 20% were born in Italy. 
In the previous year, 10% had a single fall and 5% had two or more falls. Sixty four percent 
had a low IPSS, 29% had an intermediate IPSS and 7% had a high IPSS. Seven percent had 
more than weekly but less than daily incontinence and 7% had at least daily incontinence. A 
higher proportion of men in higher IPSS categories reported two or more falls in the past 
year (low IPSS: 4%, intermediate IPSS: 7% and high IPSS:  8%). 
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Table 6.1  Baseline characteristics of men included in the analysis from the Concord Health 
and Ageing in Men Project (n=1390) 
      IPSS at baseline 
Baseline 
characteristics 
  
Total 
n=1390 
Low 
(0-7) 
n=840 
Intermediate 
(8-19) 
n=381 
High 
(20-35) 
n=90 
Age (mean+SD)  76.3+5.2 76.1+5.1 76.5+5.3 76.8+5.0 
Country of birth* 
(N(%)) 
Australia 686 (49) 426 (51) 200 (52) 35 (39) 
Italy 273 (20) 156 (19) 65 (17) 28 (31) 
Great Britain 62 (4) 39 (5) 19 (5) 3 (3) 
Greece 59 (4) 33 (4) 14 (4) 5 (6) 
China 43 (3) 27 (3) 13 (3) 0 (0) 
Other 267 (19) 159 (19) 70 (18) 19 (21) 
History of falls  
in previous year 
(N(%)) 
None 1162 (85) 738 (88) 300 (79) 71 (79) 
Once 140 (10) 65 (8) 55 (14) 12 (13) 
Twice or more 73 (5) 33 (4) 26 (7) 7 (8) 
Incontinence 
(N(%)) 
<Weekly 1181 (86) 787 (94) 297 (78) 47 (53) 
>Weekly, <Daily 99 (7) 33 (4) 43 (11) 18 (20) 
>Daily 91 (7) 20 (2) 41 (11) 23 (26) 
Dizziness 
(N(%)) 
No 1035 (75) 672 (80) 260 (68) 56 (63) 
Yes 339 (25) 165 (20) 120 (32) 33 (37) 
Walking aid use 
(N(%)) 
No 1351 (97) 817 (97) 375 (98) 84 (93) 
Yes 39 (3) 23 (3) 6 (2) 6 (7) 
Visual impairment 
(N(%)) 
20/60 and over 1311 (97) 795 (97) 361 (98) 85 (94) 
below 20/60  38 (3) 24 (3) 7 (2) 5 (6) 
Psychotropic 
medication use 
(N(%)) 
No 1234 (89) 758 (90) 327 (86) 75 (83) 
Yes 156 (11) 82 (10) 54 (14) 15 (17) 
Antihypertensive 
medication use 
(N(%)) 
No 622 (45) 380 (45) 166 (44) 38 (42) 
Yes 768 (55) 460 (55) 215 (56) 52 (58) 
IPSS, International Prostate Symptom Score. SD, standard deviation. 
The sum of numbers in each category may not add up to the total number because of 
missing data. 
*No other country contributed more than 3%. 
 
  
106 
 
Table 6.2 shows the associations between LUTS, the IPSS, urgency/urgency incontinence 
status and composite storage symptoms/urgency incontinence status and fall rates. Results 
from multivariate analyses are described below. Among individual symptoms on the IPSS, 
urgency and intermittency that occurred at least half the time were significantly associated 
with an increased fall rate and there seemed to be a dose-response relationship between 
frequency of these symptoms and fall rate. High total IPSS, intermediate to high IPSS storage 
subscores and high IPSS voiding subscores were associated with an increased fall rate. 
Urgency incontinence was significantly associated with an increased fall rate, but non-
urgency incontinence was not. With regards to the combination of urgency incontinence 
and urgency, urgency incontinence was associated with an increased fall rate, but urgency 
without urgency incontinence was not. With regards to the combination of urgency 
incontinence and composite storage symptoms (urgency, frequency and nocturia), storage 
symptoms were significantly associated with an increased fall rate even in the absence of 
urgency incontinence. 
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Table 6.2  Incidence rate ratio of falls in community-dwelling older men from the Concord 
Health and Ageing in Men Project (n=1390) 
    Men 
n 
Falls 
n 
Univariate IRR 
(95% CI) 
Multivariate IRR 
(95% CI) 
Storage symptoms         
Frequency Not at all 467 122 1.00 1.00 
<1/2 the time 565 183 1.20 (0.85-1.70) 1.21 (0.85-1.73) 
>1/2 the time 261 79 1.23 (0.80-1.87) 1.10 (0.71-1.70) 
Urgency Not at all 749 171 1.00 1.00 
<1/2 the time 383 118 1.35 (0.95-1.90) 1.20 (0.84-1.71) 
>1/2 the time 220 102 2.08 (1.40-3.09) 1.62 (1.08-2.42) 
Nocturia 0-1 time 615 152 1.00 1.00 
2-3 times 617 191 1.26 (0.92-1.74) 1.13 (0.82-1.55) 
>4 times 134 54 1.54 (0.93-2.57) 1.18 (0.71-1.97) 
Voiding symptoms         
Straining Not at all 1097 296 1.00 1.00 
<1/2 the time 191 71 1.32 (0.87-2.02) 1.36 (0.89-2.07) 
>1/2 the time 62 20 1.23 (0.61-2.49) 1.22 (0.59-2.50) 
Weak stream Not at all 754 184 1.00 1.00 
<1/2 the time 344 113 1.31 (0.91-1.87) 1.37 (0.95-1.97) 
>1/2 the time 245 91 1.62 (1.10-2.40) 1.47 (0.99-2.19) 
Intermittency Not at all 858 207 1.00 1.00 
<1/2 the time 318 104 1.36 (0.95-1.94) 1.43 (0.99-2.06) 
>1/2 the time 174 75 1.93 (1.26-2.97) 1.87 (1.23-2.85) 
Incomplete 
emptying 
Not at all 863 235 1.00 1.00 
<1/2 the time 314 92 1.05 (0.73-1.52) 1.17 (0.80-1.69) 
>1/2 the time 175 57 1.35 (0.86-2.10) 1.29 (0.83-2.00) 
IPSS         
Total IPSS Low (0-7) 840 197 1.00 1.00 
Intermediate (8-19) 381 129 1.38 (0.98-1.93) 1.29 (0.91-1.82) 
High (20-35) 90 45 2.44 (1.41-4.22) 2.06 (1.20-3.54) 
IPSS storage 
subscore 
Low (0-3) 702 132 1.00 1.00 
Intermediate (4-8) 461 177 1.99 (1.43-2.76) 1.73 (1.24-2.40) 
High (9-15) 148 62 2.43 (1.53-3.86) 1.81 (1.13-2.90) 
IPSS voiding 
subscore 
Low (0-4) 973 247 1.00 1.00 
Intermediate (5-11) 264 97 1.41 (0.97-2.05) 1.41 (0.97-2.04) 
High (12-20) 74 27 1.87 (1.02-3.46) 1.98 (1.09-3.60) 
Incontinence         
Incontinence 
by frequency 
<Weekly 1181 316 1.00 1.00 
>Weekly, <Daily 99 42 1.60 (0.93-2.75) 1.34 (0.77-2.32) 
>Daily 91 37 1.72 (0.99-3.00) 1.13 (0.65-1.99) 
Incontinence 
by type 
No (<Weekly) 1181 316 1.00 1.00 
Non-urgency 83 11 0.49 (0.23-1.04) 0.45 (0.21-0.94) 
Urgency 107 68 2.56 (1.59-4.15) 1.87 (1.15-3.04) 
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    Men 
n 
Falls 
n  
Univariate IRR 
(95% CI) 
Multivariate IRR 
(95% CI) 
Combinations of urgency incontinence and other OAB symptoms 
Urgency/ 
Urgency 
incontinence 
Neither 1083 265 1.00 1.00 
Urgency without  
urgency incontinence 
161 57 1.60 (1.03-2.48) 1.33 (0.85-2.06) 
Urgency incontinence 107 68 2.85 (1.76-4.63) 2.05 (1.25-3.36) 
Storage 
symptoms/ 
Urgency 
incontinence 
Neither 689 129 1.00 1.00 
Storage symptoms without 
urgency incontinence 
521 186 2.01 (1.46-2.76) 1.72 (1.24-2.38) 
Urgency incontinence 107 68 3.77 (2.29-6.22) 2.57 (1.54-4.30) 
 
IRR, incidence rate ratio. IPSS, International Prostate Symptom Score. OAB, overactive 
bladder. 
In multivariate models, the associations were adjusted for age, country of birth, dizziness, 
visual impairment, arthritis, psychotropic medication use, antihypertensive medication use, 
and walking aid use. 
*For the analysis by storage symptoms and urgency incontinence, having storage symptoms 
was defined as intermediate to high IPSS-S (4-15 points). 
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DISCUSSION 
This population-based prospective study showed that both lower urinary tract storage and 
voiding symptoms are associated with falls in community-dwelling older men. The strongest 
association was found for urgency incontinence occurring more than weekly. Also, storage 
symptoms (urgency, frequency and nocturia) as a whole, represented as intermediate to 
high IPSS storage subscores, were associated with falls independently of urgency 
incontinence.  
A large, well-conducted prospective study of 5872 men by Parsons et al examined a wide 
range of LUTS for associations with falls, but unlike our study, it did not account for 
incontinence (65). This study found weak associations between individual symptoms on the 
IPSS and total IPSS and falls (80). In our study with a smaller sample size, only urgency, 
intermittency and total IPSS were associated with falls. In addition, we found that both 
storage and voiding subscores were associated with falls and neither had apparently 
stronger association than the other. 
Urgency incontinence was associated with falls in our study, but other types of incontinence 
were not. This is consistent with studies in women (81, 82). Urgency has also been 
associated with falls in past studies in both men and women (23, 77), but these studies did 
not assess leakage of urine. In our study, urgency was further examined for association with 
falls by the presence of urgency incontinence to see if leakage of urine makes any additional 
contribution to fall risk beyond urgency alone. We defined urgency and incontinence as 
those occurring half the time and more than weekly respectively which we considered were 
clinically important. Urgency incontinence was moderately associated with falls, but urgency 
without urgency incontinence was not.  As a post-hoc analysis, OAB symptoms as a whole, 
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represented as IPSS-S, was examined for association with falls by the presence of urgency 
incontinence, which is the most severe form of OAB. We found that intermediate to high 
IPSS storage subscores were associated with falls even in the absence of urgency 
incontinence.  This indicates that storage symptoms collectively contribute to fall risk 
although urgency alone, without accounting for frequency and nocturia, does not make an 
independent contribution to fall risk. 
Our study has a number of strengths. CHAMP involves a large, representative sample of 
community-dwelling older Australian men. While the response rate was relatively low 
(47%), the prevalence of major medical conditions and distributions of responses to a 
question on self-rated health are similar to those in 915 men aged 70 years and over in the 
nationally representative MATeS study (45). Validated questionnaires were used to assess a 
whole range of LUTS, falls were ascertained prospectively and the associations were 
adjusted for an extensive list of previously identified fall risk factors. 
A limitation of our study is that, inherent in the study design, our results only apply to 
community-dwelling men without conditions that are related to both LUTS and falls 
(dementia, poor mobility and neurological diseases. These exclusions were made because in 
the presence of these conditions that can cause both LUTS and falls, the hypothesis of LUTS 
causing falls cannot be tested. Another limitation is that ascertainment of falls relied on 
recall of past four months without using fall diaries. Although this is not ideal, Mackenzie et 
al reported that recalls of falls in last 6 months were reliable in people aged 70 and over 
(74). Besides, the quality of responses are unlikely to have varied according to LUTS status. 
In determining LUTS, we did not discriminate between nocturnal micturition with and 
without urgency (83). This could have masked the possible association between nocturnal 
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urgency and falls. Lastly and most importantly, causality is unclear since we could not 
determine the circumstances of the falls. It is, therefore, uncertain whether medical, 
surgical or behavioural interventions for LUTS alone can reduce falls in community-dwelling 
older people (74). Since falls are often multifactorial, other predisposing or precipitating 
factors for falls that were not fully adjusted for may be playing a part in the increased fall 
risk. The circumstances of falls in men with LUTS should be investigated to generate 
hypotheses about what types of interventions may be incorporated into multidimensional 
fall prevention strategies. Also, future trials to treat LUTS should consider including falls as 
an endpoint. 
 
CONCLUSIONS 
Both lower urinary tract storage and voiding symptoms are associated with falls in 
community-dwelling older men. In particular, urgency incontinence (incontinence with an 
urgency component including mixed incontinence) carries a higher risk of falls. Also, storage 
symptoms are collectively associated with falls even in the absence of urgency incontinence. 
Other types of incontinence and urgency alone without urgency incontinence were not 
associated with falls.  
Evidence is lacking about whether treatment of LUTS decreases fall risk in community-
dwelling men. The circumstances of falls among men with LUTS should be explored to 
generate hypotheses regarding potential interventions. Furthermore, trials to treat LUTS in 
older men should consider including falls as an endpoint. 
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7. Circumstances of falls in community-dwelling 
older people with LUTS: a pilot study 
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ABSTRACT 
Background  Although lower urinary tract symptoms (LUTS) have been found to be 
associated with falls in community-dwelling older people, it is unclear whether LUTS directly 
cause falls or are merely markers of other falls risk factors. 
Methods  Outpatients aged 70 and over attending the urology clinics at Concord Hospital for 
LUTS who had had falls in the previous 12 months were interviewed between November 
2015 and October 2016. Patients who live in residential aged care facilities and those with 
cognitive impairment or limited English language proficiency were excluded. Participants 
were asked the circumstances of their recent falls (up to three) in the previous 12 months 
either face-to-face or on the phone. 
Results  Eight men and four women between ages 70 and 94 were interviewed who 
reported the circumstances of 26 falls in total. Of these 26 falls, five falls occurred in the 
process of urination.  These five falls occurred in four patients all of whom had overactive 
bladder (OAB) and were using walking aids. Three of these falls occurred in the patients’ 
own homes on their way to the toilet to urinate of whom two fell in daytime and the other 
when he woke up at night. The other two falls occurred when getting up from toilet seats 
after urinating in daytime. Sample size was limited because the frequency of falls was low 
and many patients did not speak sufficient English language to be interviewed. 
 Conclusion  Of the 26 falls in older patients with LUTS, 23 were not directly related to 
voiding and only three occurred on their way to the toilet both in daytime and at night in 
patients with OAB. It is possible that urgency and nocturia directly precipitated a minority of 
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falls although causality is still unclear. It may be worth exploring if interventions to treat or 
manage these symptoms are effective in reducing falls.  
 
INTRODUCTION 
Lower urinary tract symptoms (LUTS) such as incontinence, urgency, frequency and nocturia 
have been associated with falls in community-dwelling older people (23, 77). Since none of 
the studies that examined the association, including our own (Chapter 7) (84), determined 
the circumstances of the falls, it is unclear how LUTS contribute to falls risk. LUTS may 
directly cause falls: for example, people with incontinence may slip over leaked urine on the 
floor; or people with urgency may fall when they rush to the toilet. It is also possible that 
LUTS indirectly cause falls: for example, noturia may cause daytime sleepiness resulting in 
falls. An alternative explanation for the association between LUTS and falls is that there are 
common risk factors for both LUTS and falls, such as neurological disorders and cognitive 
impairment, that could not be fully adjusted for in previous studies. 
In this pilot study, we investigated the circumstances of the recent falls (up to three) in the 
previous 12 months in community-dwelling older people who were attending urology clinics 
for LUTS to determine if there were any instances of falls directly precipitated by LUTS. If 
this were the case, interventions to treat or manage LUTS should be incorporated into fall 
prevention strategies. 
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METHODS 
This study was conducted at clinics in the Department of Urology at Concord Hospital, 
Sydney, Australia, between November 1, 2015 and October 31, 2016. The Concord Hospital 
Human Research Ethics Committee approved the study. Written informed consent was 
obtained from all participants. 
All patients aged 70 and over attending the clinics for LUTS were screened if they had had at 
least one fall in the previous 12 months. If so, they were invited to take part in the study. 
Patients who live in residential aged care facilities and those who did not have capacity to 
give informed consent because of cognitive impairment or limited understanding of spoken 
and written English language were excluded from the study.  
Recruitment was planned in three clinics that have about 15 patients per week in total. We 
estimated that six patients per week are seen for LUTS, are 70 and older, speak English and 
live in the community. Because one in three community-dwelling older people fall in a year 
(ref 56) and people with urinary symptoms may have twice as much fall risk without 
adjusting for confounders (ref 22), we estimated that four patients per week would have 
fallen in the previous year. In 40 weeks in a year, 160 patients may be eligible and 80% may 
agree to participate in the study. We, therefore, intended to interview 130 patients. 
Participants were given a choice of telephone or face-to-face interview, either of which took 
approximately 10 minutes. Information on demographics, mobility and circumstances of up 
to three most recent falls in the previous 12 months was collected using a standardised data 
collection form (Figure 7.1, pp.114-121). For each fall, the interviewer confirmed that the 
patient landed on a lower level (41). Classification of the reason of the falls, activity at the 
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time and location were based on previous studies that investigated the circumstances of 
falls, and we added specific questions to investigate whether the falls were related to 
voiding or nocturia. 
If the participants agreed for us to interview partners or family members that they live with, 
the nominated persons were asked the same questions about circumstances of falls as were 
asked to participants. 
The participants’ medical files were reviewed to collect data on LUTS and medical history. 
Information on LUTS was also collected using the International Prostate Symptoms Score 
(IPSS) (5), and the International Consultation of Incontinence Questionnaire (ICIQ) (34) at 
the time of the interview. Information on medical history and medication use was collected 
from the medical files using the data collection form (Figure 7.2, p.122). 
The characteristics of the patients and circumstances of the falls were summarized using 
frequency distribution. 
 
RESULTS 
During the study period, 640 patients visited the clinics of whom 14 were identified to be 
eligible. Of these 14 patients, two declined to be interviewed.  We do not know the reasons 
why each patient was ineligible and/or was not able to be recruited. Table 1 shows the 
characteristics of the 12 participants who took part in the study. They were eight men and 
four women between ages 70 and 94. Seven were born in Australia, eight were using 
walking aid and nine had major cardiovascular or neurological comorbidities. Ten had 
overactive bladder (OAB) of whom six had incontinence with an urgency component and the 
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other two had stress incontinence post-transurethral resection of the prostate (TURP). In 
the previous 12 months, four had had a single fall and eight had recurrent falls. Three had 
more than three falls, but detail was only collected on the three most recent falls.  
 
Table 7.1 Characteristics of the study participants (n=12) 
Baseline characteristics   
   
Age (years) Mean 80.3 
 Range 70-94 
Sex (n) Male 8 
 Female 4 
Country of birth (n) Australia 7 
 Overseas 5 
Walking aid use (n) Yes 8 
 No 4 
Comorbidities (n) Cardiovascular disease 7 
 Neurological disorder 2 
Number of  
medications (n) 
5 or more 7 
0 to 4 5 
LUTS (n) OAB with incontinence 6 
 OAB without incontinence 4 
 Post-TURP incontinence 2 
Number of falls  
in previous year (n) 
1 4 
2 2 
3 3 
4 or more 3 
LUTS = lower urinary tract symptoms. OAB = overactive bladder. TURP = transurethral 
resection of the prostate. 
 
These 12 participants reported the circumstances of 26 falls in total. Of these 26 falls, five 
falls occurred in the process of urination. These five falls occurred in four patients all of 
whom had OAB and were using walking aids. 
Three of these participants fell on their way to the toilet. All of them were wearing 
absorbent pads at the time of the falls. Two of them were walking to the toilet in their own 
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homes in daytime, one of whom admitted both fear of leakage and being in a hurry. No 
particular environmental hazards were mentioned but one lost balance and legs gave way 
for the other. The other participant fell when he was getting out of bed to urinate at night. 
He was delirious due to urinary tract infection which required hospitalization on the 
following day but denied dizziness, fear of leakage and being in a hurry. 
The other two falls that occurred in the process of urination took place when the 
participants stood up from toilet seats in daytime in their own homes. These falls appeared 
to be due to loss of balance and support failure but participants denied dizziness and 
environmental hazards. 
Cohabiting partners and family members were interviewed for all five participants who lived 
with other people; there were no major discrepancies in the information provided. 
 
DISCUSSION 
We interviewed older patients with LUTS about the circumstances of their falls to determine 
whether LUTS directly cause falls. The interviewed patients who had LUTS and had fallen in 
the previous 12 months all appeared frail on the basis that they had gait instability requiring 
walking aids and/or had major comorbidities and the majority of the falls were not directly 
related to voiding. Gait instability and multiple comorbidities are falls risk factors (33) and 
this is in keeping with the hypothesis that older people with LUTS also have other falls risk 
factors.  We did, however, identify a few instances of falls that might possibly have been 
directly precipitated by LUTS. 
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Three patients with OAB fell on their way to the toilet and one of them admitted hurrying. 
These falls are consistent with the findings of a study that investigated the circumstances of 
falls in community-dwelling older people (85). They reported that 31% of the observed falls 
occurred when people were hurrying and 20% attributed their falls to not looking where 
they were going, although it was unclear what proportion were hurrying or lacked attention 
due to urgency to urinate. Urgency may also force abrupt movement which can result in 
falls. 
The other two patients with OAB fell when getting up from toilet seats after urinating. In 
fact, the bathroom is a common location of falls in older people (86), but the contribution of 
LUTS to these falls over the normal activities of toileting and bathing has been unclear. It is 
possible that orthostatic or post-micturition hypotension precipitated these falls, but it is 
less likely that LUTS directly precipitated these falls given the fall occurred after urination.  
Nocturia has been associated with falls (23, 77) and a number of hypotheses have been 
suggested to explain this association. It is possible that sleepiness and poor vision when 
going to the toilet at night, orthostatic hypotension when getting up from a lying position, 
and daytime sleepiness due to sleep deprivation increase falls risk. Also, there might be 
underlying comorbidities such as depression and pain that cause insomnia and also 
predispose individuals to falls (33). One patient in our study fell when he got up to urinate at 
night. Although delirium seemed to be the major precipitating factor of this fall, we cannot 
rule out the contribution of nocturia to this fall through the above mechanisms. 
The major limitation of this paper is the small sample size since we enrolled far less patients 
into the study than we expected. We could not keep track of why each patient was excluded 
because this would have added significant workload for clinic staff who screened patients. 
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Our impression, however, is that the frequency of falls was very low and that many patients 
did not speak sufficient English language to be interviewed. Since many patients were 
accompanied by family and friends, shame or embarrassment may have affected their 
responses about falls. As for the language barrier, the study hospital is located in a 
multicultural area in Sydney and we would have been able to recruit more patients if we 
translated patient information sheet and had interpreters present. Since our sample size 
was very small, we may have missed other important circumstances of falls. For example, 
the above-mentioned study about the circumstances of falls also reported that 19% slipped 
on wet or slippery surface (85) and it is possible that people slip over leaked urine. It would 
be useful to further investigate the circumstances of falls to generate more hypotheses 
about what types of intervention may be effective. In future studies, ascertainment of falls 
may need to be done in privacy and reasonable efforts need to be made to overcome 
language barrier. We conducted this study in urology clinic patients to maximize efficiency 
but the issue could also be studied in a large population-based study of falls. 
In conclusion, in this small study of older people with LUTS, those who reported falling had 
features of frailty such as gait instability and major comorbidities and the majority of falls 
were not directly related to voiding. This finding is consistent with the hypothesis that older 
people with LUTS are more likely to fall because of shared risk factors for LUTS and falls. 
However, three out of 26 falls in older patients with LUTS occurred in those with OAB on 
their way to the toilet both during the day and when they woke to urinate at night. It is 
possible that urgency and nocturia directly precipitated these falls. It may be worth 
exploring if the treatment and management of these symptoms are effective ways of 
reducing falls for some older people.  
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Figure 7.1  Data collection form for circumstances of falls 
 
A study on circumstances of falls in older people with urinary symptoms living in the community 
Data Collection Form (telephone/face-to-face interview) 
Date: 
Participant number: 
 
CHARACTERISTICS OF PARTICIPANT 
Q1  Who else lives with you at home? 
1=lives alone, 2=spouse or partner, 3=children, 4=relatives, 5=friends, 6=others (give details) 
_______________________________________________________________ 
Q2  Since leaving school, have you obtained a trade qualification, certificate, diploma or any other 
qualification? 
1==no, 2=bachelor degree or higher, 3=trade/apprenticeship, 4=certificate/diploma, 5=other (give 
details) 
______________________________________________________________  
Q3  In which country were you born? 
1=Australia, 2=New Zealand, 3=United Kingdom, 4=Italy, 5=Greece, 6=Europe (other), 7=Middle East,  
8=China/Hong Kong, 9=Vietnam, 10 other (give details) 
________________________________________ 
Q4  What walking aid do you usually use to help you move about inside the house? 
1=no walking aid, 2=walking stick, 3=pick-up frame, 4= rollator, 5= need help of others,  
6=independent on wheel chair, 7=immobile 
Q5  What walking aid do you usually use to help you move about outside the house? 
1=no walking aid, 2=walking stick, 3=pick-up frame, 4= rollator, 5= need help of others,  
6=independent on wheel chair, 7=immobile 
 
FALLS 
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 A fall is an event when you accidentally come to rest on the ground, floor or other lower level. 
Q1 Have you fallen in the past 12 months?   
1=Yes, 2=No >End of interview 
Q1.1 If yes, how many times did you fall in the past 12 months?           times 
  
123 
 
Tell us about the most recent fall over the past year.  
Q2.1  When did you last fall?  
_______________________________________________________________________ 
Q2.2 What time of the day was it when you last fell? 
1=morning (after rising from bed to midday),  
2=afternoon (before it gets dark), 3=evening (before bedtime) >Skip next question 
4=night (bedtime to rising), 5=unsure 
Q2.2.1  (If the fall occurred at night) Did you take sleeping pills before going to bed?  1=No, 2=Yes, 
3=unsure  
Q2.3 Did you have a poor vision when you fell? 1=No, 2=Yes, 3=unsure 
Q2.4  What were you doing at that time? 
1=getting out of bed, getting out of a chair/couch, 3=getting up from toilet/out of bath/shower, 
4=walking indoors, walking ourdoors, 6=outdoors activity (sports etc), 7=others (give details), 
8=unsure 
__________________________________________________________________________________
_____________ 
Q2.5  Describe why you fell? 
1=slip, 2=trip, 3=loss of balance, 4=legs gave way, 4=dizziness/light-headedness, 5=support failure, 
6=blackout/faint, 7=unclear/cannot remember, 8=other (give details), 9=unsure 
___________________________________   
___________________________________________________________                                                                                                                                      
Q2.6  Did this fall require medical attention? 
1=no, 2=GP, 3=ED attendance, 4=hospital admission, 5=other (give details) 
__________________________________________________________________________________
_____________ 
Q2.7  Did this fall occur in any of the following circumstances? 
1=On your way to or inside of the toilet when you urinated 
2=Other circumstances that you think was related to urination (give 
details)_________________________________ 
3=Nothing related to urination >Go to next page if two or more falls 
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If the fall happened on your way or inside of toilet, or in other circumstances that you think was 
related to urination, 
Q2.7.1  Were you afraid of leaking urine?  1=No, 2=Yes, 3=unsure 
Q2.7.2  Were you wearing absorbent pads/underwear/diapers?  1=No, 2=Yes, 3=unsure   
Q2.7.3  Were you hurrying?  1=No, 2=Yes, 3=unsure 
Q2.7.4  Were you dizzy?  1=No, 2=Yes, 3=unsure 
Q2.7.5  Did you just rise up from chair or bed?  1=Within a minute, 2=After a minute, 3=unsure 
Q2.7.6  Did you slip on leaked urine?  1=No, 2=Yes, 3=unsure >Continue to next page if two or more 
falls  
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Tell us about the second most recent fall over the past year.  
Q3.1  When was your second last fall?  
_______________________________________________________________ 
Q3.2 What time of the day was it when you had your second last fall? 
1=morning (after rising from bed to midday),  
2=afternoon (before it gets dark), 3=evening (before bedtime) >Skip next question 
4=night (bedtime to rising) , 5=unsure 
Q3.2.1  (If the fall occurred at night) Did you take sleeping pills before going to bed?  1=No, 2=Yes, 
3=unsure 
Q3.3 Did you have a poor vision when you fell? 1=No, 2=Yes, 3=unsure 
Q3.4  What were you doing at that time? 
1=getting out of bed, getting out of a chair/couch, 3=getting up from toilet/out of bath/shower, 
4=walking indoors, walking ourdoors, 6=outdoors activity (sports etc), 7=others (give details) , 
8=unsure 
__________________________________________________________________________________
_____________ 
Q3.5  Describe why you fell? 
1=slip, 2=trip, 3=loss of balance, 4=legs gave way, 4=dizziness/light-headedness, 5=support failure, 
6=blackout/faint, 7=unclear/cannot remember, 8=other (give details) , 9=unsure 
___________________________________   
___________________________________________________________                                                                                                                                      
Q3.6  Did this fall require medical attention? 
1=no, 2=GP, 3=ED attendance, 4=hospital admission, 5=other (give details) 
__________________________________________________________________________________
_____________ 
Q3.7  Did this fall occur in any of the following circumstances? 
1=On your way to or inside of the toilet when you urinated 
2=Other circumstances that you think was related to urination (give 
details)_________________________________ 
3=Nothing related to urination >Go to next page if three or more falls 
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If the fall happened on your way or inside of toilet, or in other circumstances that you think was 
related to urination, 
Q3.7.1  Were you afraid of leaking urine?  1=No, 2=Yes, 3=unsure 
Q3.7.2  Were you wearing absorbent pads/underwear/diapers?  1=No, 2=Yes , 3=unsure   
Q3.7.3  Were you hurrying?  1=No, 2=Yes, 3=unsure 
Q3.7.4  Were you dizzy?  1=No, 2=Yes, 3=unsure 
Q3.7.5  Did you just rise up from chair or bed?  1=Within a minute, 2=After a minute, 3=unsure 
Q3.7.6  Did you slip on leaked urine?  1=No, 2=Yes, 3=unsure >Continue to next page if three or 
more falls  
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Tell us about the third most recent fall over the past year.  
Q4.1  When was your third last fall?  
_________________________________________________________________ 
Q4.2 What time of the day was it when you had your third last fall? 
1=morning (after rising from bed to midday),  
2=afternoon (before it gets dark), 3=evening (before bedtime) >Skip next question 
4=night (bedtime to rising) , 5=unsure 
Q4.2.1  (If the fall occurred at night) Did you take sleeping pills before going to bed?  1=No, 2=Yes, 
3=unsure 
Q4.3 Did you have a poor vision when you fell? 1=No, 2=Yes , 3=unsure 
Q4.4  What were you doing at that time? 
1=getting out of bed, getting out of a chair/couch, 3=getting up from toilet/out of bath/shower, 
4=walking indoors, walking ourdoors, 6=outdoors activity (sports etc), 7=others (give details) , 
8=unsure 
__________________________________________________________________________________
_____________ 
Q4.5  Describe why you fell? 
1=slip, 2=trip, 3=loss of balance, 4=legs gave way, 4=dizziness/light-headedness, 5=support failure, 
6=blackout/faint, 7=unclear/cannot remember, 8=other (give details) , 9=unsure 
___________________________________   
___________________________________________________________                                                                                                                                      
Q4.6  Did this fall require medical attention? 
1=no, 2=GP, 3=ED attendance, 4=hospital admission, 5=other (give details) 
__________________________________________________________________________________
_____________ 
Q4.7  Did this fall occur in any of the following circumstances? 
1=On your way to or inside of the toilet when you urinated 
2=Other circumstances that you think was related to urination (give 
details)_________________________________ 
3=Nothing related to urination 
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If the fall happened on your way or inside of toilet, or in other circumstances that you think was 
related to urination, 
Q4.7.1  Were you afraid of leaking urine?  1=No, 2=Yes, 3=unsure 
Q4.7.2  Were you wearing absorbent pads/underwear/diapers?  1=No, 2=Yes, 3=unsure     
Q4.7.3  Were you hurrying?  1=No, 2=Yes, 3=unsure 
Q4.7.4  Were you dizzy?  1=No, 2=Yes, 3=unsure 
Q4.7.5  Did you just rise up from chair or bed?  1=Within a minute, 2=After a minute, 3=unsure 
Q4.7.6  Did you slip on leaked urine?  1=No, 2=Yes, 3=unsure 
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Figure 7.2  Data collection form for medical history and medication use 
 
A study on circumstances of falls in older people with urinary symptoms living in the community 
Data Collection Form (medical records) 
 
Date: 
Participant number: 
 
Medical history 
 
Urological conditions  __________________________________________________ 
Urological procedures  _________________________________________________ 
 
          Cognitive impairment 
          Neurological diseases  _____________________________________________ 
          Poor vision 
          Depression 
Other  _______________________________________________________________   
 
Medications 
          Psychotropic medications  __________________________________________ 
          Antihypertensive medications  _______________________________________ 
Other  _______________________________________________________________ 
 
Photocopy IPSS and ICIQ. 
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8. Thesis summary, discussion and conclusions 
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8.1 Natural history of common urological conditions in community-dwelling older men 
The first aim of this thesis was to determine the natural history of two common urological 
conditions, non-neurogenic overactive bladder (OAB) and elevated post-void residual urine 
volume (PVR), in community-dwelling older men. The CHAMP study data were utilized to 
address these questions. The key conclusion from these studies was that, in the absence of 
neurological disorders, OAB often resolves spontaneously and most cases of elevated PVR 
remain stable. Each study is further discussed in the following sections. 
8.1.1 Natural history of non-neurogenic OAB in community-dwelling older men 
In the study presented in Chapter 3, we found that one in three men experienced natural 
and sustained remission of non-neurogenic OAB over five years. Our findings in untreated 
men sampled from the community support initial conservative management of OAB in 
primary care. 
On the other hand, as many as two in three experienced either recurrent or persistent OAB, 
and we were not able to identify risk factors for persistent OAB because the sample size of 
men with OAB in the CHAMP study was small. Since OAB significantly diminishes quality of 
life (QOL), as discussed in section 1.2, it would be useful if we could identify patients who 
are not likely to experience continuous remission so that behavioural or pharmacological 
treatment can be implemented sooner. To obtain a sufficient sample size to analyse the 
predictors of persistent OAB would require a large cohort study of untreated patients with 
OAB rather than a population study.  
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8.1.2 Natural history of elevated PVR in community-dwelling older men 
In the study presented in Chapter 4, we found that most men with PVR of less than 400mL 
did not require treatment for elevated PVR, and that PVR did not exceed 400mL in the next 
five years in the absence of neurological disorders. In addition, hospitalizations for UTI and 
urinary retention were rare. Elevated PVR is often detected incidentally and there is 
uncertainty about optimal management. This is because there has been insufficient 
evidence as to what level of elevated PVR results in complications and whether or how 
quickly elevated PVRs may progress. Our study indicates that most community-dwelling 
men with elevated PVR of up to 400mL, after excluding neurological disorders, may be 
safely managed without intervention for at least five years. 
In contrast, three out of the four men with a baseline PVR of 400mL and over underwent 
surgery for BPE over five years, one of whom also received indwelling catheterization after a 
surgery. This would suggest that men with a PVR of 400mL and over need to be monitored 
closely, with the caveat that this recommendation is based on our finding in a small sample 
of men.  
Renal failure is another potential adverse outcome of elevated PVR that we did not look at 
in this study. This is because elevated PVR rarely affect creatinine levels: a case series by 
George et al showed that normal creatinine levels can be maintained even in the presence 
of elevated PVR of 475mL and over and significant dilatation of the upper urinary tract (87). 
For interest, a post-hoc analysis in our study showed that, in the few men with very high 
PVR of 400mL and over, there was no clinically important elevation of serum creatinine. 
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As many as 25% of the otherwise eligible men for this study were excluded because they did 
not void at least 150mL and, therefore, their PVR data were regarded as invalid. Our data 
show that a great majority of these men simply did not have sufficient urine left in the 
bladder: their median PVR was 21mL. This occurred because men were not specifically 
asked to drink water before the urodynamic tests. We judged that it would be confusing if 
we ask men to fast for blood test but to drink plenty of water, and that men would worry 
about having to urinate on their way to the clinic. This is a weakness of our study that 
looked at many aspects of older men’s health compared to studies that focused specifically 
on urological outcomes. For example, in the Olmsted County study of urinary symptoms, 
instruction was given to drink water before urodynamic tests and the tests were 
rescheduled if men voided less than 150mL (88). 
 
8.2 Associations between LUTS and falls in community-dwelling older men 
The second aim of this thesis was to explore the associations between LUTS and falls in 
community-dwelling older men. This was achieved by taking a multi-method approach as 
summarized in Figure 8.1. In Chapter 5, we conducted a systematic review on the 
association between LUTS and falls, injuries and fractures in community-dwelling older men. 
We found that both incontinence and storage symptoms were associated with falls but, 
from this review, we could not determine which of these symptoms, that often coexist in 
men, contribute to fall risk. This was addressed in Chapter 6 where we examined the 
contribution of each LUTS to falls risk in community-dwelling older men in the CHAMP 
study. In this study, we found that urgency incontinence and both storage and voiding 
symptoms were associated with falls, and that storage symptoms collectively contribute to 
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falls risk even in the absence of urgency incontinence. Lastly, since it is unclear in both men 
and women whether LUTS directly cause falls or are merely markers of other fall risk factors, 
the urology clinic pilot study presented in Chapter 7 investigated the circumstances of falls 
in older patients of both sexes to find out whether LUTS directly precipitate falls. We 
observed that some people with OAB and poor mobility fell on their way to the toilet both 
during the day and when they woke up at night. 
 
Figure 8.1 Summary of the findings (associations between LUTS and falls) 
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Our systematic review found that no study in community-dwelling men looked at injuries as 
an outcome and the few studies that examined the associations between LUTS and 
fractures lacked power because fractures are less frequent in men than women. After our 
systematic review was completed, Marshall et al published a prospective study about the 
association between LUTS and non-spine fractures from a maximum of eight-year follow-up 
of 5989 men in the MrOS cohort (80). Even in such a long follow-up of a large number of 
men, they did not find an association between LUTS and non-spine fractures after adjusting 
for potential confounders. This alone, however, does not negate the importance of LUTS as 
a risk factor for falls because adverse outcomes of falls are not limited to fractures or 
injuries directly caused by falls but also include fear of falling and self-imposed activity 
restriction as discussed in section 1.4. 
In previous studies of the associations between LUTS and falls in both men and women, 
nocturia has been consistently associated with falls (23, 77). In the CHAMP study, however, 
no significant association was found between nocturia and falls. Since many older men have 
insomnia and may habitually go to the toilet when they wake up at night, simply counting 
episodes of urination during night time cannot differentiate between true nocturia and 
insomnia. Differentiating nocturnal micturition with and without urgency would allow us to 
isolate the effect of true nocturia on falls from that of poor sleep quality. One way this could 
be done is to record the presence or absence of urgency at each void: in a pharmacological 
trial to treat OAB, Weiss et al determined the degree of urgency at each void using the five-
point Urgency Sensation Scale that the study participants recorded in a bladder diary (83).  
In the urology clinic pilot study about the circumstances of falls, the only instances of falls 
that we identified that could possibly have been precipitated by LUTS were those in patients 
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with OAB that occurred on their way to the toilet. Since our sample size was small, it is 
possible that LUTS precipitate falls in other ways such as slips on leaked urine. It would be 
useful to identify more of the circumstances of LUTS-precipitated falls to generate 
hypotheses about what kind of interventions may be effective in preventing falls. Since 
Concord Hospital is located in a multicultural area in Sydney, many older patients in our 
clinics did not speak sufficient English language to be interviewed. Future studies may need 
to involve family and friends who accompany the patients and ask fewer and simpler 
questions. 
To answer the question of whether treating LUTS reduces falls or not, ultimately, 
randomized controlled trials (RCTs) of medical or behavioural intervention for LUTS to 
prevent falls are necessary. There have been two RCTs to treat LUTS with falls prevention as 
the primary outcome in nursing home residents but none has been done in community-
dwelling older people (75). One trial was a multidimensional intervention including 
prompted toileting and physical exercise which successfully reduced falls (89). But the other 
trial of a bladder-specific anticholinergic medication was unsuccessful (90). Since 
anticholinergic medications can cause adverse effects that are risk factors for falls such as 
blurred vision, tachycardia, confusion and cognitive impairment especially in older people, it 
is difficult to predict the direction of the effect of these medications on falls. Future studies 
of pharmacological treatment of LUTS in older patients should consider including falls as an 
outcome to answer this question. Furthermore, circumstances of falls should be further 
investigated among older people with LUTS, and then behavioural interventions based on 
these findings should be incorporated into multifactorial fall prevention strategies and be 
tested for efficacy.  
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Concord Repatriation General Hospital 
A study on circumstances of falls in older people  
with urinary symptoms living in the community 
INFORMATION FOR PARTICIPANTS 
The Urology Department and the Centre for Education and Research on Ageing at Concord 
Hospital is conducting the above-named study. This study has been approved by the Concord 
Hospital Human Research Committee in October, 2015, and will be carried out at Concord 
Hospital from November 2015 to October 2016. 
Urinary symptoms (such as incontinence or urgency to go to toilet) are thought to increase 
the risk of falls. It is not known, however, how people with urinary symptoms fall. Knowing 
more about this may improve prevention measures for falls. 
For this study, information on falls that you may have had in the past year will be obtained 
from either a telephone or face-to-face interview. If possible, we would also like to contact 
your partner or family who lives with you for more information about your falls. Recall of 
events at the time of falls can be unclear even in people with good memory. Also we will 
review your medical file to obtain information on urinary symptoms, medical history and 
medication use.  
All details obtained will remain confidential. A report of this study may be published, but 
individual participants will not be identifiable by any means in such a report. The original 
data in paper files will be stored in a locked cabinet. Electronic data will be stored at a 
password-protected computer system. 
What does it mean for me? 
Participation to this study is completely voluntary. You may choose to refuse or withdraw 
from this study at any time, and if you choose to do so, it will not in any way affect your 
medical care. You may also elect for us not to contact your partner or family but take part in 
the study yourself. 
We will call you or arrange a face-to-face interview to gather the falls information. Either can 
be arranged at a suitable time for your convenience. The interview will take no more than 10 
minutes either way. We will ask about details of any falls you might have had in the last 12 
months. We also ask a few questions about your living arrangements (do you live alone or 
not?), country of birth, qualifications and mobility. 
Your usual medical care will not be interrupted, and any information relevant to your medical 
care will be relayed to your treating doctors. 
Your partner or family member whom you nominate will be contacted to arrange a telephone 
or face-to-face interview. S/he will be asked about details of any falls you might have had in 
the last 12 months. We will not be asking them about anything else to do with your health or 
about them. 
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Further information 
If you would like to know more at any stage, please feel free to contact Ms Naomi Noguchi, 
PhD student, at Centre for Education and Research on Ageing on (02) 9767 9170. If you have 
any concerns or complaints about the conduct of the research study, you may contact the 
Secretary of the Concord Hospital Human Research Ethics Committee, on (02) 9767 5622. 
Alternatively, if you wish to speak with an independent person within the Hospital about any 
problems or queries about the way in which the study was conducted, you may contact the 
Patient Representative on (02) 9767 7488.  
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Concord Repatriation General Hospital 
A study on circumstances of falls related to urinary symptoms  
in older people living in the community 
PARTICIPANT CONSENT FORM 
 
I,  .………………………………………………………………..…….………[name]  
of………………………………………………………………………………[address]  
have read and understood the Information for Participants for the above named research study 
and have discussed the study with  ………………………………………………… 
……………………………………...  
 I have been made aware of the procedures involved in the study, including any known or 
expected inconvenience, risk, discomfort or potential side effect and of their implications 
as far as they are currently known by the researchers. 
 
 I understand that, during the course of this study, my medical records may be accessed by 
the researchers, by regulatory authorities or by the Ethics Committee approving the 
research in order to verify results and determine that the study is being carried out correctly. 
 
 I freely choose to participate in this study and understand that I can withdraw at any time. 
 
 I also understand that the research study is strictly confidential. 
 
 I hereby agree to participate in this research study. 
 
      Please tick the box if we can contact your partner or family who lives with you. 
      Who can we contact? Name:………………………   Phone:………………………… 
 
Name (Please Print): ........................................................................................................ . 
 
Signature:.........................................................  Date:  ..................................................  
 
Name of Person who conducted informed consent discussion (Please Print): 
 
………………………………………………………………………………………… 
Signature of Person who conducted informed consent discussion: 
 
Signature:.........................................................  Date:  ..................................................  
 
